US20220378690A1 - Compositions and methods for treating skin - Google Patents
Compositions and methods for treating skin Download PDFInfo
- Publication number
- US20220378690A1 US20220378690A1 US17/818,749 US202217818749A US2022378690A1 US 20220378690 A1 US20220378690 A1 US 20220378690A1 US 202217818749 A US202217818749 A US 202217818749A US 2022378690 A1 US2022378690 A1 US 2022378690A1
- Authority
- US
- United States
- Prior art keywords
- weight
- extract
- oil
- composition
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 212
- 238000000034 method Methods 0.000 title claims abstract description 32
- 239000000284 extract Substances 0.000 claims abstract description 146
- 238000001802 infusion Methods 0.000 claims abstract description 126
- 239000003921 oil Substances 0.000 claims abstract description 123
- 235000018625 Helichrysum angustifolium Nutrition 0.000 claims abstract description 41
- 235000013530 Helichrysum italicum Nutrition 0.000 claims abstract description 41
- 235000005865 Symphytum officinale Nutrition 0.000 claims abstract description 38
- 240000002299 Symphytum officinale Species 0.000 claims abstract description 38
- 235000000060 Malva neglecta Nutrition 0.000 claims abstract description 35
- 240000000982 Malva neglecta Species 0.000 claims abstract description 35
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 30
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 28
- 239000000341 volatile oil Substances 0.000 claims abstract description 25
- 235000018081 Hibiscus syriacus Nutrition 0.000 claims abstract description 23
- 244000130592 Hibiscus syriacus Species 0.000 claims abstract description 23
- 229940002386 calendula officinalis extract Drugs 0.000 claims abstract description 23
- 229940085784 viola tricolor extract Drugs 0.000 claims abstract description 23
- 231100000121 skin sensitizing Toxicity 0.000 claims abstract description 21
- 230000000887 hydrating effect Effects 0.000 claims abstract description 20
- 230000036559 skin health Effects 0.000 claims abstract description 18
- 235000006770 Malva sylvestris Nutrition 0.000 claims abstract description 16
- 240000002129 Malva sylvestris Species 0.000 claims abstract description 16
- 230000037075 skin appearance Effects 0.000 claims abstract description 15
- 230000002708 enhancing effect Effects 0.000 claims abstract description 13
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 10
- 244000292571 Helichrysum italicum Species 0.000 claims abstract 9
- 235000019198 oils Nutrition 0.000 claims description 119
- 241000186660 Lactobacillus Species 0.000 claims description 47
- 229940039696 lactobacillus Drugs 0.000 claims description 47
- 239000003755 preservative agent Substances 0.000 claims description 44
- 235000019489 Almond oil Nutrition 0.000 claims description 39
- 239000008168 almond oil Substances 0.000 claims description 39
- 230000002335 preservative effect Effects 0.000 claims description 35
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 27
- 244000060011 Cocos nucifera Species 0.000 claims description 27
- 239000006071 cream Substances 0.000 claims description 25
- 235000013399 edible fruits Nutrition 0.000 claims description 24
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims description 21
- 239000002253 acid Substances 0.000 claims description 18
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 16
- 229960004889 salicylic acid Drugs 0.000 claims description 16
- 150000003839 salts Chemical class 0.000 claims description 16
- 239000000499 gel Substances 0.000 claims description 13
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims description 5
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 5
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- 239000006210 lotion Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 230000001010 compromised effect Effects 0.000 abstract description 11
- 210000003491 skin Anatomy 0.000 description 153
- 239000000047 product Substances 0.000 description 64
- 239000004615 ingredient Substances 0.000 description 53
- 244000000182 Helichrysum angustifolium Species 0.000 description 32
- 235000015112 vegetable and seed oil Nutrition 0.000 description 29
- 241000196324 Embryophyta Species 0.000 description 27
- 239000002537 cosmetic Substances 0.000 description 27
- 240000001432 Calendula officinalis Species 0.000 description 19
- 230000006872 improvement Effects 0.000 description 19
- 239000008158 vegetable oil Substances 0.000 description 19
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 18
- 235000005881 Calendula officinalis Nutrition 0.000 description 18
- 239000004302 potassium sorbate Substances 0.000 description 18
- 235000010241 potassium sorbate Nutrition 0.000 description 18
- 229940069338 potassium sorbate Drugs 0.000 description 18
- 230000036541 health Effects 0.000 description 17
- 244000047670 Viola x wittrockiana Species 0.000 description 16
- 235000004031 Viola x wittrockiana Nutrition 0.000 description 16
- 230000008859 change Effects 0.000 description 16
- 230000001815 facial effect Effects 0.000 description 15
- 238000005259 measurement Methods 0.000 description 15
- 238000012360 testing method Methods 0.000 description 14
- 230000008901 benefit Effects 0.000 description 13
- 239000000463 material Substances 0.000 description 13
- 239000003208 petroleum Substances 0.000 description 13
- 230000036571 hydration Effects 0.000 description 11
- 238000006703 hydration reaction Methods 0.000 description 11
- 239000004909 Moisturizer Substances 0.000 description 10
- 230000001333 moisturizer Effects 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 210000002615 epidermis Anatomy 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 230000000975 bioactive effect Effects 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 230000007794 irritation Effects 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 206010070835 Skin sensitisation Diseases 0.000 description 6
- 238000002845 discoloration Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000003974 emollient agent Substances 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- 230000001681 protective effect Effects 0.000 description 6
- 235000005713 safflower oil Nutrition 0.000 description 6
- 239000003813 safflower oil Substances 0.000 description 6
- 230000008591 skin barrier function Effects 0.000 description 6
- 230000037393 skin firmness Effects 0.000 description 6
- 231100000370 skin sensitisation Toxicity 0.000 description 6
- 230000036548 skin texture Effects 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 230000000699 topical effect Effects 0.000 description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 5
- 230000003631 expected effect Effects 0.000 description 5
- 229920002674 hyaluronan Polymers 0.000 description 5
- 229960003160 hyaluronic acid Drugs 0.000 description 5
- 150000004677 hydrates Chemical class 0.000 description 5
- 230000031700 light absorption Effects 0.000 description 5
- -1 parabens Chemical compound 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 230000036572 transepidermal water loss Effects 0.000 description 5
- 244000056974 Adansonia digitata Species 0.000 description 4
- 235000003320 Adansonia digitata Nutrition 0.000 description 4
- 235000003319 Adansonia gregorii Nutrition 0.000 description 4
- 244000144927 Aloe barbadensis Species 0.000 description 4
- 235000002961 Aloe barbadensis Nutrition 0.000 description 4
- 241000208983 Arnica Species 0.000 description 4
- 240000000560 Citrus x paradisi Species 0.000 description 4
- 240000008067 Cucumis sativus Species 0.000 description 4
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 4
- 241000227647 Fucus vesiculosus Species 0.000 description 4
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 4
- 240000000950 Hippophae rhamnoides Species 0.000 description 4
- 240000001439 Opuntia Species 0.000 description 4
- 235000013389 Opuntia humifusa var. humifusa Nutrition 0.000 description 4
- 244000178231 Rosmarinus officinalis Species 0.000 description 4
- 235000019485 Safflower oil Nutrition 0.000 description 4
- 241000320380 Silybum Species 0.000 description 4
- 235000010841 Silybum marianum Nutrition 0.000 description 4
- 244000044822 Simmondsia californica Species 0.000 description 4
- 235000004433 Simmondsia californica Nutrition 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- 235000011399 aloe vera Nutrition 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 239000001071 citrus reticulata blanco var. mandarin Substances 0.000 description 4
- 239000003240 coconut oil Substances 0.000 description 4
- 235000019864 coconut oil Nutrition 0.000 description 4
- 230000018044 dehydration Effects 0.000 description 4
- 238000006297 dehydration reaction Methods 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 235000008995 european elder Nutrition 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 239000010774 macerated oil Substances 0.000 description 4
- 230000037311 normal skin Effects 0.000 description 4
- 230000003204 osmotic effect Effects 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 239000010667 rosehip oil Substances 0.000 description 4
- 210000002374 sebum Anatomy 0.000 description 4
- 230000037067 skin hydration Effects 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 239000010496 thistle oil Substances 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 229920000715 Mucilage Polymers 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 239000002385 cottonseed oil Substances 0.000 description 3
- 235000012343 cottonseed oil Nutrition 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000004626 essential fatty acids Nutrition 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 238000009499 grossing Methods 0.000 description 3
- 239000000944 linseed oil Substances 0.000 description 3
- 235000021388 linseed oil Nutrition 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- 230000037394 skin elasticity Effects 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- ZOIAPLVBZQQHCG-UHFFFAOYSA-N 3-[[3-acetyl-2,4,6-trihydroxy-5-(3-methylbut-2-enyl)phenyl]methyl]-6-ethyl-4-hydroxy-5-methylpyran-2-one Chemical compound CC1=C(CC)OC(=O)C(CC=2C(=C(C(C)=O)C(O)=C(CC=C(C)C)C=2O)O)=C1O ZOIAPLVBZQQHCG-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 235000007460 Coffea arabica Nutrition 0.000 description 2
- 240000007154 Coffea arabica Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 description 2
- 229940087168 alpha tocopherol Drugs 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- 239000010478 argan oil Substances 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 239000010480 babassu oil Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000011712 cell development Effects 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 229940021231 clearskin Drugs 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- 239000002285 corn oil Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 229940075946 dermatop Drugs 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000003810 hyperpigmentation Effects 0.000 description 2
- 208000000069 hyperpigmentation Diseases 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 238000002803 maceration Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000008164 mustard oil Substances 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 235000017807 phytochemicals Nutrition 0.000 description 2
- 229930000223 plant secondary metabolite Natural products 0.000 description 2
- FNPXMHRZILFCKX-KAJVQRHHSA-N prednicarbate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)CC)(OC(=O)OCC)[C@@]1(C)C[C@@H]2O FNPXMHRZILFCKX-KAJVQRHHSA-N 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 235000020238 sunflower seed Nutrition 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 229940025703 topical product Drugs 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 229940046001 vitamin b complex Drugs 0.000 description 2
- 239000010497 wheat germ oil Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 235000004835 α-tocopherol Nutrition 0.000 description 2
- 239000002076 α-tocopherol Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- ZPSJGADGUYYRKE-UHFFFAOYSA-N 2H-pyran-2-one Chemical compound O=C1C=CC=CO1 ZPSJGADGUYYRKE-UHFFFAOYSA-N 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 235000009027 Amelanchier alnifolia Nutrition 0.000 description 1
- 244000068687 Amelanchier alnifolia Species 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 241000454552 Astrocaryum murumuru Species 0.000 description 1
- 235000000016 Astrocaryum murumuru Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 241000132023 Bellis perennis Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 235000003717 Boswellia sacra Nutrition 0.000 description 1
- 235000012035 Boswellia serrata Nutrition 0.000 description 1
- 240000007551 Boswellia serrata Species 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 235000005976 Citrus sinensis Nutrition 0.000 description 1
- 240000002319 Citrus sinensis Species 0.000 description 1
- 235000010205 Cola acuminata Nutrition 0.000 description 1
- 244000228088 Cola acuminata Species 0.000 description 1
- 235000015438 Cola nitida Nutrition 0.000 description 1
- 241000159174 Commiphora Species 0.000 description 1
- 240000007311 Commiphora myrrha Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- 235000005664 Crambe maritima Nutrition 0.000 description 1
- 244000174788 Crambe maritima Species 0.000 description 1
- 108060002063 Cyclotide Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 241001632410 Eleutherococcus senticosus Species 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 241000508725 Elymus repens Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 244000223604 Mauritia flexuosa Species 0.000 description 1
- 235000010080 Mauritia flexuosa Nutrition 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 241000123069 Ocyurus chrysurus Species 0.000 description 1
- 206010033372 Pain and discomfort Diseases 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 235000009321 Pouteria lucuma Nutrition 0.000 description 1
- 244000266507 Pouteria lucuma Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 235000009001 Quillaja saponaria Nutrition 0.000 description 1
- 241001454523 Quillaja saponaria Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 235000018087 Spondias lutea Nutrition 0.000 description 1
- 244000063498 Spondias mombin Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 244000141804 Theobroma grandiflorum Species 0.000 description 1
- 235000002424 Theobroma grandiflorum Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical group NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 244000078534 Vaccinium myrtillus Species 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- DWUMRQPTCMDVJD-NPARFUQOSA-N alpha-D-GlcpA4Me-(1->2)-beta-D-Xylp-(1->4)-beta-D-Xylp-(1->4)-beta-D-Xylp Chemical compound O1[C@H](C(O)=O)[C@@H](OC)[C@H](O)[C@@H](O)[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)OC3)O)OC2)O)OC[C@@H](O)[C@@H]1O DWUMRQPTCMDVJD-NPARFUQOSA-N 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000007321 biological mechanism Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000019216 blueberry extract Nutrition 0.000 description 1
- 229940055416 blueberry extract Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 229940082906 centella asiatica leaf extract Drugs 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 150000001907 coumarones Chemical class 0.000 description 1
- 235000020237 cranberry extract Nutrition 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 230000001632 homeopathic effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 239000005414 inactive ingredient Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 230000005722 itchiness Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 239000006014 omega-3 oil Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000009329 organic farming Methods 0.000 description 1
- 235000013348 organic food Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000003209 petroleum derivative Substances 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 150000003000 phloroglucinols Chemical class 0.000 description 1
- 125000002444 phloroglucinyl group Chemical group [H]OC1=C([H])C(O[H])=C(*)C(O[H])=C1[H] 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 229940030967 physalis angulata extract Drugs 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000020746 red clover extract Nutrition 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000006254 rheological additive Substances 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 229930185460 santinol Natural products 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- ODFAPIRLUPAQCQ-UHFFFAOYSA-M sodium stearoyl lactylate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O ODFAPIRLUPAQCQ-UHFFFAOYSA-M 0.000 description 1
- 229940080352 sodium stearoyl lactylate Drugs 0.000 description 1
- KANINNSSRWMGIP-UHFFFAOYSA-M sodium;butyl 4-hydroxybenzoate;dodecyl sulfate;hexadecan-1-ol;methyl 4-hydroxybenzoate;octadecan-1-ol;propane-1,2-diol;propyl 4-hydroxybenzoate Chemical compound [Na+].CC(O)CO.COC(=O)C1=CC=C(O)C=C1.CCCOC(=O)C1=CC=C(O)C=C1.CCCCOC(=O)C1=CC=C(O)C=C1.CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCOS([O-])(=O)=O.CCCCCCCCCCCCCCCCCCO KANINNSSRWMGIP-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229940100515 sorbitan Drugs 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 229940013368 zanthoxylum bungeanum fruit extract Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
Definitions
- the disclosure relates to compositions and methods of enhancing the health and appearance of human skin using botanical ingredients, and more particularly to moisturizing compositions, preservatives therefor, and methods of using the same.
- Extrinsic influences include ultraviolet radiation, environmental pollution, extreme temperatures, harsh surfactants, contamination from consumer products, oxidative stress, and mechanical stress caused by, for example, shaving, abrasions, and the like.
- Intrinsic influences include chronological aging, a person's genetic makeup, skin homogeneity, skin-barrier function, thickness of the skin layer, degradation of the extracellular matrix, the activity level of particular genes, nuclear cell function, and other biological changes, such as scarring, that occur from within the skin. Regardless of the specific cause, these factors result in the development of fine lines and wrinkles, sagging, and loss of elasticity and firmness, which are oftentimes associated with an attendant reduction in the skin's moisture content.
- Dry skin is a particularly common disorder that affects both males and females equally, and is particularly prevalent in older individuals and those genetically predisposed to such a condition. People suffering from dry skin complain of flaking, itching, irritation, and an overall dull, rough and lackluster appearance to their skin. Moreover, as a person ages, their skin tends to produce fewer natural oils that aid in preventing moisture from escaping from the skin, and as a result older individuals are more prone to dehydration.
- a moisturizing composition commonly contains emollients, preservatives, fragrances, and emulsifiers to hold the composition's ingredients together. Any or all of these categories of ingredients may contain synthetic and/or petroleum-based ingredients.
- the emollient which aids in retaining moisture in the skin may be formed from petroleum and/or synthetic alcohols and may form a waterproof barrier on the skin.
- synthetic emollients are known to cause irritation or harm to the skin, to not soothe or provide necessary nutrients to the skin, and to be ineffective at moisturizing the skin, particularly over time. Synthetic emollients that are excessively occlusive, such that moisture is trapped against the skin, can interfere with normal skin function.
- Synthetic preservatives such as phenoxyethanol, parabens, formaldehyde donors, and other compounds can cause skin irritation and other serious health issues.
- Synthetic fragrances may likewise cause skin irritation and may be toxic.
- Non-plant-based emulsifiers usually comprise petroleum derivatives.
- preservative formulation has become a cottage industry with consumers gravitating towards products containing natural extracts, botanicals, or other ingredients derived from natural sources, while avoiding those products having ingredients that are either known to cause or suspected of causing adverse health reactions.
- this ad hoc approach and decentralization of acquired knowledge and experience of generating effective preservative formulations has led to a host of ineffective solutions that typically result in diminished shelf-life and usability of associated topical consumer products.
- ECOCERT® is an organic certification organization based in Europe that conducts inspections in over 80 countries, making it one of the largest organic certification organizations in the world. ECOCERT® primarily certifies food and food products but also certifies cosmetics, detergents, perfumes, and textiles and is a leading certifier of fair-trade food, cosmetics, and textiles.
- COSMOS Cosmetic Organic Standard
- BDIH Germany
- Cosmebio France
- Ecocert Greenlife SAS France
- ICEA Italy
- Soil Association Great Britain
- AISBL international non-profit organization based in Brussels
- COSMOS makes use of the principles in the ECOCERT® standard: to promote the use of ingredients from organic farming, use production and manufacturing processes that are environmentally sound and safe for human health, and include and expand the concept of “green chemicals.”
- the National Organic Program (NOP) a federal regulatory framework in the United States governing organic food, is yet another certification.
- the core mission of the NOP is to protect the integrity of the United States Department of Agriculture (USDA) organic seal.
- USDA United States Department of Agriculture
- the seal is used for products adhering to USDA standards that contain at least 95% organic ingredients.
- Embodiments of the present disclosure are directed to a skincare composition intended for enhancing skin health and appearance and containing: (1) a moisturizing/hydrating-effective amount of a mixture of at least: (a) an oil infusion of Calendula officinalis extract; (b) an oil infusion of Helichrysum italicum extract; (c) an oil infusion of Symphytum officinale extract; (d) an aqueous infusion of Viola tricolor extract; and (e) an aqueous infusion of at least one Mallow extract, such as and/or selected from Althea officinalis and/or Malva sylvestris ; and (2) an emulsifying-effective amount of a dermatologically acceptable emulsifier, wherein the composition is all-natural and free of a skin sensitizing-effective amount of a volatile essential oil.
- the present disclosure is also directed to a skincare composition intended for enhancing skin health and appearance containing: (1) a natural preservative system; (2) a moisturizing/hydrating-effective amount of a mixture of at least: (a) an oil infusion of Calendula officinalis extract; (b) an oil infusion of Helichrysum italicum extract; (c) an oil infusion of Symphytum officinale extract; (d) an aqueous infusion of Viola tricolor extract; and (e) an aqueous infusion of at least one Mallow extract, such as and/or selected from Althea officinalis and/or Malva sylvestris ; and (3) an emulsifying-effective amount of a dermatologically acceptable emulsifier, wherein the composition is natural and free of a skin sensitizing-effective amount of a volatile essential oil.
- a natural preservative system (2) a moisturizing/hydrating-effective amount of a mixture of at least: (a) an oil infusion of Cal
- the present disclosure is also directed to a skincare composition intended for enhancing skin health and appearance comprising a moisturizing/hydrating-effective amount of a mixture of (1) a natural preservative system; and (2) at least one of an Elderflower hydrosol, infusions of Milk Thistle oil, Castor oil, Safflower oil, and Grapefruit essential oil, and jojoba beads.
- the present disclosure is also directed to a skincare composition intended for enhancing skin health and appearance comprising a moisturizing/hydrating-effective amount of a mixture of (1) a natural preservative system; and (2) at least one of cucumber, aloe vera, and infusions of Arnica oil and Bladder Wrack oil.
- the present disclosure is also directed to a skincare composition intended for enhancing skin health and appearance comprising a moisturizing/hydrating-effective amount of a mixture of (1) a natural preservative system; and (2) at least one of Calendula -infused oil and water, Serrated Wrack; Hyaluronic acid; Sweet Almond oil; and Green Mandarin oil.
- the present disclosure is also directed to a skincare composition intended for enhancing skin health and appearance comprising a moisturizing/hydrating-effective amount of a mixture of (1) a natural preservative system; and (2) at least one of Rosehip oil, Bog Myrtle, Sea Buckthorn, Prickly Pear Seed oil, Serrated Wrack, Rosemary, Kiwi Seed oil, and Baobab oil.
- the present disclosure is also directed to a method of enhancing skin health and appearance by applying one of the above-disclosed skincare compositions onto the skin.
- the present disclosure is also directed to a method of treating compromised skin by applying one of the above-disclosed skincare compositions onto the skin.
- the use of the word “natural” is intended to encompass ECOCERT®-approved ingredients or formulations synonymous with the terms “green,” “clean,” “organic,” “sustainable,” “eco-friendly,” or “environmentally-friendly” as known and used in the art.
- the term “natural,” for example, may be used in the context of holistic or homeopathic formulations and is intended to include those topical consumer products and/or preservative systems that are plant-based, paraben-free, and/or non-toxic.
- a “broad spectrum” preservative system inhibits the growth of or kills a wide range of bacteria and fungi, preferably a wide range of Gram-positive and Gram-negative bacteria, yeasts, molds, and/or other fungi.
- compositions of the present invention can comprise, consist essentially of, or consist of, the components of the present invention as well as other ingredients described herein.
- the term “comprising” as used herein is meant to include various optional, compatible components that can be used in the preservative systems and cosmetic compositions of the present disclosure.
- the term “consisting essentially of” as used herein means that the composition or component may include additional ingredients, but only if the additional ingredients do not materially alter the basic and novel characteristics of the compositions or methods.
- the words “preferred”, “preferably” and variants thereof refer to embodiments of the disclosure that afford certain benefits under certain circumstances. However, other embodiments may also be preferred under the same or other circumstances. Furthermore, the recitation of one or more preferred embodiments does not imply that other embodiments are not useful and is not intended to exclude other embodiments from the scope of the disclosure.
- Compromised skin as described herein means skin that suffers from symptoms such as dryness, flakiness, itchiness, and irritation.
- Compromised skin can be caused by extrinsic and/or intrinsic influences, as noted above.
- Extrinsic influences include, in addition to the influences discussed previously, sunburn, pollution, use of hard-surface cleaning products having harsh chemicals, and mechanical stress associated with shaving and certain dermatological procedures such as laser, microdermabrasion, micro-needling or chemical peel therapy.
- Intrinsic influences include, in addition to the influences discussed previously, conditions such as eczema and dermatitis.
- the use of a topical product can effectively moisturize/hydrate the skin in response to such intrinsic influences, thereby alleviating some of the pain and discomfort experienced by individuals suffering from the above-referenced symptoms.
- skin-sensitizing effective amount as described herein is meant to describe an amount of a volatile essential oil that can lead to an allergic response following contact with an individual's skin.
- Skin sensitization is an immunological response to previous exposure to a substance that results in an inflammatory skin reaction.
- An allergic skin reaction is usually presented as a red, itchy, bumpy rash.
- Examples of the types of volatile essential oils that can cause skin sensitization, depending on their amounts within a skincare composition include, but are not limited to, frankincense, myrrh, and sweet orange.
- the present disclosure generally relates to a skincare composition that not only effectively enhances skin health and appearance when topically applied thereon, but also serves to help alleviate symptoms associated with compromised skin.
- the skincare composition is also natural, organic and ECOCERT®-approved, thus being free of harmful synthetic and/or petroleum-derived ingredients.
- a skincare composition that is both all-natural and free of skin-sensitizing ingredients, containing a mixture of specific botanical infusions comprised of at least: an oil infusion of Calendula officinalis extract; an oil infusion of Helichrysum italicum extract; an oil infusion of Symphytum officinale extract; an aqueous infusion of Viola tricolor extract; and an aqueous infusion of at least one Mallow extract, such as or selected from Althea officinalis and/or Malva sylvestris , when applied onto skin, both moisturizes and hydrates the skin, and helps the skin retain/lock-in this moisture, thereby enhancing both its health and appearance and, if the skin is also compromised, helps to alleviate symptoms associated therewith.
- a mixture of specific botanical infusions comprised of at least: an oil infusion of Calendula officinalis extract; an oil infusion of Helichrysum italicum extract; an oil infusion of Symphytum officinale
- Calendula officinalis extract is derived from the common marigold plant.
- Common bioactive compounds found therein include, for example, flavonoids, phenolic acids, carotenoids, triterpenic alcohols, polycarbohydrates, proteins, amino acids, saturated hydrocarbons, vitamin C, and mineral substances.
- the Calendula officinalis extract of the present disclosure is preferably employed in an amount of from about 0.3 to about 0.6% by weight, and most preferably in an amount of about 0.5% by weight, all weights based on the total weight of the skincare composition.
- the Calendula officinalis extract is employed in the form of an oil infusion.
- the oil component of the infusion is preferably employed in an amount of from about 1 to about 3% by weight, and most preferably in an amount of about 2% by weight, based on the total weight of the composition.
- Calendula officinalis beneficially brings moisturizing and soothing properties to dry or irritated skin, thereby helping to protect the skin.
- Calendula officinalis stimulates physiological healing and regeneration of wounded skin and aids the skin in retaining hydration.
- Calendula officinalis improves skin distensibility, firmness, and viscoelasticity, in part by increasing blood flow to the area of application and encouraging tissue regeneration.
- Helichrysum italicum extract contains numerous bioactive compounds including, for example, phenolics such as heterodimeric phloroglucinyl pyrone arzanol, angeloylated glycerides known as santinols, coumarates, benzofurans, pyrones, and heterodimeric phloroglucinols.
- phenolics such as heterodimeric phloroglucinyl pyrone arzanol, angeloylated glycerides known as santinols, coumarates, benzofurans, pyrones, and heterodimeric phloroglucinols.
- the Helichrysum italicum extract of the present disclosure is preferably employed in an amount of from about 0.9 to about 1.3% by weight, and most preferably in an amount of about 1.2% by weight, all weights based on the total weight of the skincare composition.
- the Helichrysum italicum extract is employed in the form of an oil infusion.
- the oil component of the infusion is preferably employed in an amount of from about 4 to about 7% by weight, and most preferably in an amount of about 4.7% by weight, based on the total weight of the composition.
- Helichrysum italicum has emollient properties and creates a protective film to retain moisture and keep the skin hydrated.
- the primary bioactive compounds found in Symphytum officinale extract include allantoin, rosmarinic acid and ellagic acid.
- the Symphytum officinale extract of the present disclosure is preferably employed in an amount of from about 0.3 to about 0.6% by weight, and most preferably in an amount of about 0.5% by weight, all weights based on the total weight of the skincare composition.
- the Symphytum officinale extract is employed in the form of an oil infusion.
- the oil component of the infusion is preferably employed in an amount of from about 1 to about 3% by weight, and most preferably in an amount of about 2% by weight, based on the total weight of the composition.
- Symphytum officinale provides keratolytic properties to shed dry, outer layers of the epidermis, thereby helping to maintain a healthy level of moisture and an improved appearance of the skin.
- a particularly preferred oil component is almond oil.
- the inventors have surprisingly discovered that the use of almond oil enables bioactive compounds present in the oil infusions to effectively penetrate into the skin, without the need to use skin-sensitizing essential oils, and while still facilitating the desired degree of efficacy in terms of skin health and appearance resulting from enhanced moisturization and hydration of the skin. This is due to almond oil being rich in beta-zoosterol, squalene, and alpha-tocopherol, together with smaller amounts of carbohydrates, proteins, vitamins, and minerals such as vitamin B complex and zinc.
- Almond oil's phytochemicals are believed to be effective at promoting surface-level proliferation and skin cell development.
- Other vegetable oils include, but are not limited to, olive oil, jojoba oil, babassu oil, caster oil, coconut oil, corn oil, cotton seed oil, linseed oil, mustard oil, safflower oil, sesame oil, soybean oil, sunflower-seed oil, wheat germ oil, argan oil and manila oil.
- Viola tricolor extract Some interesting bioactive compounds found in Viola tricolor extract include small peptides known as cyclotides, flavonoids such as quercetin, luteolin and rutin, mucilages consisting of glucose, galactose, arabinose and rhamnose, as well as tannins and salicylic acid and its derivatives.
- the Viola tricolor extract of the present disclosure is preferably employed in an amount of from about 2 to about 3% by weight, and most preferably in an amount of about 2.5% by weight, all weights based on the total weight of the composition.
- the Viola tricolor extract is employed in the form of an aqueous infusion.
- Viola tricolor advantageously provides polysaccharides to boost the skin's capacity to retain water by improving osmotic function.
- the at least one Mallow extract of the present disclosure will preferably be chosen from Malva sylvestris extract and Althea officinalis extract. These Mallow extracts possess an abundance of mucilages having polysaccharides contained therein. These mucilages consist mainly of glucuronic acid, galacturonic acid, rhamnose, galactose, fructose, glucose, sucrose and trehalose, as well as lesser amounts of uronic acid, arabinose, mannose, xylose, fucose, raffinose and 2-O- ⁇ -(4-O-methyl- ⁇ -d-glucuronosyl)-xylotriose.
- the at least one Mallow extract of the present disclosure is preferably employed in an amount of from about 2 to about 3% by weight, and most preferably in an amount of about 2.5% by weight, all weights based on the total weight of the skincare composition.
- a particularly preferred Mallow extract is Althea officinalis extract.
- the Mallow extract is employed in the form of an aqueous infusion.
- the at least one Mallow extract forms a soothing protective gel that moisturizes dry, rough skin due to its mucilaginous properties, which form a thick, gluey substance.
- Both the Viola tricolor and Mallow extracts are employed as aqueous infusions, wherein the total water content of both aqueous infusions is from about 50 to about 70% by weight, and preferably about 60% by weight, all weights based on the total weight of the skincare composition.
- the skincare composition By providing a skincare composition comprising a combination of Calendula officinalis, Helichrysum italicum , and Symphytum officinale oil infusions and Viola tricolor and Mallow aqueous extracts, the skincare composition hydrates, soothes, and nourishes a user's skin in complementary ways.
- the skincare composition soothes the skin with Calendula officinalis , creates a protective moisture-retaining film with Helichrysum italicum , helps the skin shed dry outer layers of epidermis with Symphytum officinale , improves osmotic function with Viola tricolor , and forms a moisturizing and soothing protective gel with Mallow extract.
- the skincare composition benefits normal skin function by providing healing and/or nourishing compounds to protect the skin across a range of physiological functions, including shedding of dry epidermis layers, improving moisture retention, and forming natural protective films and gels to augment and supplement the skin's biological moisturizing properties.
- Calendula officinalis Helichrysum italicum, Symphytum officinale, Viola tricolor , and Mallow are further provided in specific, effective, synergistic, and targeted amounts for user health, comfort, cost, and compatibility. Moreover, as discussed in greater detail herein, the benefits and efficacy of the composition are quantifiable, reproducible, and rigorously obtained.
- the botanical oil infusions of the present disclosure are obtained using an extraction technique known as maceration.
- This technique typically performed at room temperature, involves immersing a plant in oil which functions as a solvent inside an airtight vessel for a variable amount of time based on the plant material being infused into the oil.
- the vessel in which the plant material is being macerated is periodically agitated in order to aid the solvent in penetrating the outer cell walls of the plant material.
- the resultant macerated product is then filtered in order to separate the residual plant material from the liquid.
- the residual plant material is then pressed in order to recover any excess liquid entrapped therein.
- the botanical aqueous infusions of the present disclosure are obtained using an extraction technique known as decoction. This technique involves immersing a plant in boiling water, preferably purified water, inside an airtight vessel, for a variable amount of time based on the plant material being infused into the water.
- the plant Prior to being processed, the plant is first properly washed and separated from any foreign material such as topsoil, pebbles or rocks, weeds, and other materials not suitable for extraction.
- the plant material should be used fresh in order to maintain the integrity of the bioactive components in the fresh plant matter.
- the use of dried plant material is typically not desirable due to the degradation experienced by the plant during the dehydration process.
- the cell walls are compromised resulting in the degradation of compounds through mechanisms such as hydrolysis, oxidation, polymerization, Maillard reactions, and isomerization.
- the resulting extract contains these degradation products that were not in the fresh plant matter. The presence of these degradation products can negatively impact the efficacy of the product and increase the potential for skin sensitization.
- the plant is preferably cut into small pieces.
- the pieces should not be too big, otherwise the oil will not be able to penetrate the plant's innermost cells.
- the pieces should also not be reduced to powder, as that would make it more difficult to separate the infusion from the bulk plant material via filtration once the maceration process is completed.
- an emulsifier should also be employed in order to emulsify the immiscible oil and aqueous phases of the skincare composition.
- Any ingredient capable of emulsifying the composition may be employed without departing from the spirit of the disclosure so long as it is natural and dermatologically acceptable.
- Suitable emulsifiers include, but are not limited to, glyceryl stearate, cetyl alcohol, sodium stearoyl lactylate, sorbitan olivate, cetearyl olivate, cetearyl alcohol, cetearyl glucoside, sodium cetearyl sulfate, and the like. It is also particularly preferred that the emulsifier be free of palm oil.
- a skincare composition for application onto human skin in order to enhance its health and appearance the composition containing a moisturizing/hydrating-effective amount of a mixture of at least: (a) an oil infusion of Calendula officinalis having from about 0.3 to about 0.6% by weight, and preferably about 0.5% by weight, of Calendula officinalis extract, and from about 1 to about 3% by weight, and preferably about 2% by weight of a vegetable oil, preferably almond oil; (b) an oil infusion of Helichrysum italicum having from about 0.9 to about 1.3% by weight, and preferably about 1.2% by weight, of Helichrysum italicum extract, and from about 4 to about 7% by weight, and preferably about 4.7% by weight of a vegetable oil, preferably almond oil; (c) an oil infusion of Symphytum officinale having from about 0.3 to about 0.6% by weight, and preferably about 0.5% by weight, of Symphytum officinale
- a natural preservative system comprised of a combination of specific amounts of: a Lactobacillus ferment, a Lactobacillus and Cocos nucifera (coconut) fruit extract, salicylic acid (in some embodiments optional), a salt of a weak acid such as potassium sorbate, and a petroleum-free propanediol, when incorporated into a composition having a specific pH range, effectively both prohibits and inhibits microbial growth on and in the composition.
- the Lactobacillus ferment of the present disclosure is preferably employed in an amount of from about 1 to about 5% by weight, preferably from about 2 to about 4% and more preferably from about 2 to about 4%, by weight of the total composition.
- An exemplary Lactobacillus ferment is commercially available from Active Micro Technologies under the tradename Leucidal® SF.
- the Lactobacillus and Cocos nucifera fruit extract can include any Cocos nucifera fruit extract fermented with Lactobacillus and/or included with Lactobacillus ferment of the present disclosure and is preferably employed in an amount of from about 1 to about 5%, preferably from about 2 to about 4%, by weight of the total composition.
- An exemplary Lactobacillus and Cocos nucifera extract is commercially available from Active Micro Technologies under the tradename Amticide® Coconut and is typically associated with the International Nomenclature of Cosmetic Ingredients (INCI) name of a Lactobacillus and Cocos nucifera (coconut) fruit extract.
- salicylic acid When present, salicylic acid is preferably employed in an amount of up to about 0.5% by weight, preferably from about 0.1 to about 0.45% and more preferably from about 0.2 to about 0.4%, by weight of the total composition. It should be noted that the use of salicylic acid in an amount at or greater than about 0.5% by weight, based on the total weight of the composition, renders the composition a drug requiring FDA approval in the prior to commercialization and sale in the United States.
- salicylic acid may be omitted by adjusting the concentrations of Lactobacillus ferment, Lactobacillus and Cocos nucifera fruit extract, and/or other ingredients as described in greater detail herein.
- the salt of a weak acid is preferably employed in an amount of up to about 0.5% by weight, preferably from about 0.1 to about 0.45% and more preferably from about 0.2% to about 0.4%, by weight of the total composition.
- a preferred salt of a weak acid is potassium sorbate (i.e., the potassium salt of sorbic acid).
- Other weak acids that may be used in their salt form include, but are not limited to, acetic acid, propionic acid, and benzoic acid.
- Petroleum-free 1,3-propanediol is typically employed in an amount of about 1% to about 10% by weight, preferably from about 2% to about 8% and more preferably from about 4% to about 6%, by weight of the total composition.
- An exemplary petroleum-free 1,3-propanediol is commercially available from Dupont Tate & Lyle Bio Products under the tradename Zemea® Propanediol and can be associated with the INCI name propanediol.
- the inventors have unexpectedly discovered that the ability of the preservative system of the present disclosure to effectively inhibit microorganism growth is critically dependent on the pH of the composition in which it is used. For example, if the preservative system is employed in a composition having a pH of 6, it fails to provide the requisite broad-spectrum protection needed for acceptable storage stability/shelf-life. Accordingly, the pH of a composition containing the preservative system of the present disclosure must be in a range of from about 4.5 to about 5.5, and preferably from about 4.8 to about 5.3.
- a skincare composition intended for application onto human skin in order to enhance its health and appearance, the composition containing: (1) a preservative system that includes: (a) from about 1 to about 5%, preferably from about 2 to about 4%, by weight of a Lactobacillus ferment; (b) from about 1 to about 5%, preferably from about 2 to about 4%, by weight of a Lactobacillus and Cocos nucifera fruit extract; (c) up to about 0.5%, preferably from about 0.1 to about 0.45% and more preferably from about 0.2 to about 0.4%, by weight of salicylic acid; (d) from about 0.1 to about 0.5% by weight, and preferably from about 0.2 to about 0.4% by weight of at least one salt of a weak acid, preferably potassium sorbate; and (e) from about 1 to about 10%, preferably from about 2 to about 8% and more preferably from about 4 to about 6%, by weight of a petroleum-free propanediol, preferably 1,3
- a skincare composition intended for application onto human skin in order to enhance its health and appearance, the composition containing: (1) a preservative system that includes: (a) from about 1 to about 5%, preferably from about 2 to about 4% by weight, of a Lactobacillus ferment; (b) from about 1 to about 5%, preferably from about 2 to about 4%, by weight of a Lactobacillus and Cocos nucifera fruit extract; (c) from about 0.1 to about 0.45% by weight, preferably from about 0.2 to about 0.4% of salicylic acid; (d) up to about 0.5% by weight, preferably from about 0.2 to about 0.4% by weight, of at least one salt of a weak acid, preferably potassium sorbate; and (e) from about 1 to about 10%, preferably from about 2 to about 8% by weight, and most preferably from about 4 to about 6% by weight, of a petroleum-free propanediol; (2) a moisturizing/hydrating-effective amount of a preservative system that includes: (a)
- a skincare composition intended for application onto human skin in order to enhance its health and appearance, the composition containing: (1) a preservative system that includes: (a) from about 1 to about 5%, preferably from about 2 to about 4% by weight, of a Lactobacillus ferment; (b) from about 1 to about 5%, preferably from about 2 to about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) from about 0.1 to about 0.45%, preferably from about 0.2 to about 0.4% by weight, of salicylic acid; (d) from about 0.1 to about 0.5% by weight, preferably from about 0.2 to about 0.4% by weight, of at least one salt of a weak acid, preferably potassium sorbate; and (e) from about 1 to about 10%, preferably from about 2 to about 8%, and most preferably from about 4 to about 6% by weight, of a petroleum-free propanediol; (2) a moisturizing/hydrating-effective
- a skincare composition intended for application onto human skin in order to enhance its health and appearance, the composition containing: (1) a preservative system comprised of: (a) from about 2 to about 4% by weight, of a Lactobacillus ferment; (b) from about 2 to about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) from about 0.2 to about 0.4% by weight, of salicylic acid; (d) from about 0.2 to about 0.4% by weight, of at least one salt of a weak acid, preferably potassium sorbate; and (e) from about 4 to about 6% by weight, of a petroleum-free propanediol; (2) a moisturizing/hydrating-effective amount of a mixture of at least: (f) an oil infusion of Calendula officinalis having from about 0.3 to about 0.6% by weight, and preferably about 0.5% by weight, of Calendula officinalis extract, and from about 1 to about 3%
- a skincare composition intended for application onto human skin in order to enhance its health and appearance, the composition containing: (1) a preservative system comprised of: (a) from about 2 to about 4% by weight, of a Lactobacillus ferment; (b) from about 2 to about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) from about 0.2 to about 0.4% by weight, of salicylic acid; (d) from about 0.2 to about 0.4% by weight, of at least one salt of a weak acid, preferably potassium sorbate; and (e) from about 4 to about 6% by weight, of a petroleum-free propanediol; (2) a moisturizing/hydrating-effective amount of a mixture of at least: (f) an oil infusion of Calendula officinalis having about 0.5% by weight of Calendula officinalis extract, and about 2% by weight of almond oil; (g) an oil infusion of Helichrysum it
- a skincare composition intended for application onto human skin in order to enhance its health and appearance, the composition containing: (1) a preservative system comprised of: (a) about 4% by weight, of a Lactobacillus ferment; (b) about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) about 0.4% by weight, of potassium sorbate; and (e) about 4% by weight, of a petroleum-free propanediol; (2) a moisturizing/hydrating-effective amount of a mixture of at least: (f) an oil infusion of Calendula officinalis having about 0.5% by weight of Calendula officinalis extract, and about 2% by weight of almond oil; (g) an oil infusion of Helichrysum italicum having about 1.2% by weight, of Helichrysum italicum extract, and about 4.7% by weight of almond oil; (h) an oil infusion of Symphytum officinale having about 0.
- a skincare composition may comprise (1) a preservative system comprised of: (a) about 4% by weight, of a Lactobacillus ferment; (b) about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) about 0.4% by weight, of potassium sorbate; and (e) about 4% by weight, of a petroleum-free propanediol; (2) an Elderflower hydrosol, infusions of Milk Thistle oil, Castor oil, Safflower oil, and Grapefruit essential oil, and jojoba beads; (3) about 8.5% by weight of a dermatologically acceptable emulsifier; and (4) a dermatologically acceptable carrier, all weights being based on the total weight of the composition, wherein the composition is natural, free of a skin sensitizing-effective amount of an essential oil, free of petroleum-derived ingredients, and has a pH ranging from about 4.5 to about 5.5, preferably from about 4.8 to about 5.3.
- Elderflower hydrosol provides plant acids that gently tone the skin.
- Milk Thistle oil comprises antioxidant properties to protect the skin, e.g. from UV radiation.
- Castor and Safflower oil reduce pore size, increase hydration, and offer superior cleansing abilities.
- Grapefruit essential oil provides an uplifting scent with toning properties.
- Jojoba beads provide light exfoliation without causing skin irritation.
- a composition intended for application onto human skin in order to enhance its health and appearance comprising: (1) a preservative system comprised of: (a) about 4% by weight, of a Lactobacillus ferment; (b) about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) about 0.4% by weight, of potassium sorbate; and (e) about 4% by weight, of a petroleum-free propanediol; (2) Helichrysum italicum , cucumber, aloe vera, and infusions of Arnica oil and Bladder Wrack oil; (3) about 8.5% by weight of a dermatologically acceptable emulsifier; and (4) a dermatologically acceptable carrier, all weights being based on the total weight of the composition, wherein the composition is natural, free of a skin sensitizing-effective amount of an essential oil, free of petroleum-derived ingredients, and has a pH ranging from about 4.5 to about 5.5, preferably from about 4.8 to
- Arnica oil reduces puffiness around the eyes.
- Bladder Wrack oil helps reduce moisture loss and protects the skin against irritation.
- Helichrysum italicum advantageously provides a moisture-retentive film to keep the skin hydrated, while cucumber provides amino acids, proteins, and lipids that help to pump and calm the skin. Aloe vera soothes and hydrates the skin while increasing firmness.
- a composition intended for application onto human skin in order to enhance its health and appearance comprising: (1) a preservative system comprised of: (a) about 4% by weight, of a Lactobacillus ferment; (b) about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) about 0.4% by weight, of potassium sorbate; and (e) about 4% by weight, of a petroleum-free propanediol; (2) Calendula -infused oil and water, Serrated Wrack, Hyaluronic acid from about 1 to about 3% by weight, Sweet Almond oil, and Green Mandarin oil; (3) about 8.5% by weight of a dermatologically acceptable emulsifier; and (4) a dermatologically acceptable carrier, all weights being based on the total weight of the composition, wherein the composition is natural, free of a skin sensitizing-effective amount of an essential oil, free of petroleum-derived ingredients, and has a pH ranging from about 4.5 to about 5.5
- Calendula -infused oil and water improve skin distensibility, firmness, and viscoelasticity.
- Serrated Wrack improves skin suppleness by moisturizing and improving the skin barrier.
- Hyaluronic acid in a range from, for example, about 1% by weight to about 3% by weight, boosts the skin's ability to absorb moisture and results in smoother, softer skin.
- Sweet Almond oil softens the skin. Green Mandarin oil tones and helps balance oil production in the skin.
- a composition intended for application onto human skin in order to enhance its health and appearance comprising: (1) a preservative system comprised of: (a) about 4% by weight, of a Lactobacillus ferment; (b) about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) about 0.4% by weight, of potassium sorbate; and (e) about 4% by weight, of a petroleum-free propanediol; (2) Rosehip oil, Bog Myrtle, Sea Buckthorn, Prickly Pear Seed oil, Serrated Wrack, Rosemary, Kiwi Seed oil, and Baobab oil; (3) about 8.5% by weight of a dermatologically acceptable emulsifier; and (4) a dermatologically acceptable carrier, all weights being based on the total weight of the composition, wherein the composition is natural, free of a skin sensitizing-effective amount of an essential oil, free of petroleum-derived ingredients, and has a pH ranging from about 4.5 to about
- Rosehip oil soothes, moisturizes, and softens the skin, and further contains Vitamins A and C. It is also rich in essential fatty acids. Bog Myrtle helps keep pores clean and provides antioxidants. Sea Buckthorn helps retain moisture and improve skin elasticity, and further contains vitamins, minerals, and omega-3 fatty acids. Prickly Pear Seed oil reduces hyperpigmentation, and further contains vitamins E and K and is rich in essential fatty acids. Serrated Wrack helps improve the suppleness and elasticity of the skin, and contains minerals and trace elements. Rosemary protects the skin from environmental stressors. Kiwi Seed oil controls sebum production and helps maintain clear skin. Baobab oil gives elasticity to the skin and contains vitamins A, D, E, and F.
- the skincare compositions of the present disclosure may be in a wide variety of product forms that include, but are not limited to, solutions, suspensions, lotions, creams, gels, sprays, ointments and serums.
- a product intended for application onto skin, post-shaving, in order to help relieve the irritation associated with the mechanical stress on the skin caused by the shaving process can be formulated using the above-described compositions as a base formula.
- the skincare compositions can comprise other suitable, optional ingredients as desired.
- the composition can optionally include other active or inactive ingredients, provided they do not unacceptably alter the benefits of the skincare composition, are natural, and do not promote skin sensitization.
- the precise amount of optional ingredients will be determined by those skilled in the art.
- ingredients examples include, but are not limited to, humectants, emollients, flavonoids, minerals, chelating agents, pH regulators/buffers, rheology modifiers, phytosterols, vitamin B3 compound, anti-inflammatory agents such as licorice extracts, bisabolol, manjistha extracted from plants in the genus Rubia , guggal extracted from plants in the genus Commiphora, Quillaja saponaria extract, kola extract, chamomile, red clover extract, sea whip extract, hibiscus extract, lucuma extract, sea kale extract, Iceland Moss extract, Saskatoon Berry extract, Siberian Ginseng extract, spruce needles extract, birch bark extract, blueberry extract, cranberry extract, yarrow extract, marigold extract and couch grass extract.
- anti-inflammatory agents such as licorice extracts, bisabolol, manjistha extracted from plants in the genus Rubia
- Additional ingredients that may be employed in order to further potentiate the efficacy of embodiments of the disclosure may include, for example, Astrocaryum murumuru seed butter, Theobroma grandiflorum seed butter, Spondias mombin pulp extract, Mangifera indica pulp extract, Musa sapientum pulp extract, Mauritia flexuosa fruit oil, Physalis angulata extract, Xylityl sesquicaprylate, Vaccinium myrtillus seed oil, Cucubita pepo seed extract, linoleic acid, Centella asiatica leaf extract, Tamarindus indica seed polysaccharide, Zanthoxylum bungeanum fruit extract, Lactococcus ferment lysate, Bellis perennis flower extract, Coffea arabica seed cake extract, Coffea arabica seed oil, cotton seed oil, linseed oil, Pichia ferment lysate filtrate, and whey protein.
- Astrocaryum murumuru seed butter The
- the dermatologically acceptable carrier can encompass a wide variety of forms. In some cases, the solubility or dispersibility of the components in the composition may dictate the form and character of the carrier. Non-limiting examples include simple solutions (e.g., aqueous or anhydrous), dispersions, emulsions and solid forms. In certain embodiments, the dermatologically acceptable carrier is in the form of an emulsion.
- An emulsion can be generally classified as having a continuous aqueous phase (e.g., oil-in-water and water-in-oil-in-water) or a continuous oil phase (e.g., water-in-oil or oil-in-water).
- oil phase may comprise any vegetable oil, so long as it does not cause skin sensitization
- a particularly preferred oil component is almond oil.
- the inventors have surprisingly discovered that the use of almond oil enables bioactive compounds present in the botanical extract to effectively penetrate into the skin, without the need of having to use skin-sensitizing essential oils, while still facilitating the desired degree of efficacy. This is due to almond oil being rich in beta-zoosterol, squalene, and alpha-tocopherol, together will lesser amounts of carbohydrates, proteins, vitamins and minerals such as vitamin B complex and zinc.
- almond oil's phytochemicals are believed to be effective at promoting surface level proliferation and skin cell development.
- Other vegetable oils that may also be used include, but are not limited to, olive oil, jojoba oil, babassu oil, caster oil, coconut oil, corn oil, cotton seed oil, linseed oil, mustard oil, safflower oil, sesame oil, soybean oil, sunflower-seed oil, wheat germ oil, argan oil and manila oil.
- the present disclosure is also directed to a method of treating compromised skin by applying one of the above-disclosed compositions onto the compromised skin.
- Example 1 The composition of Example 1 was clinically tested in order to determine its efficacy in enhancing skin health and appearance. Thirty-six individuals aged 45-65 were asked to apply the composition twice a day at home, once in the morning and once in the evening, under normal use conditions, as a replacement for their normal skin treatment routine. Skin health and appearance data were collected on day zero, day 28, day 56, and day 84.
- the skin-smoothing and anti-wrinkle effect of the composition was determined in-vivo using the fringe projection system DermaTOP® and its attendant acquisition software. This system measures the height of projections in ⁇ m emanating from the skin used to assess skin roughness and severity of wrinkles on the skin. A decrease in projection height evidences smoother, less wrinkled skin. The data clearly evidence the skin-smoothing/anti-wrinkling effect of the composition, as shown in Table 1 below.
- the skin-firming effect of the composition was determined using an add-on to the DermaTOP® system known as DynaSKIN® and its attendant dedicated software.
- This system measures the skin-deformation parameters of volume, surface and depth associated with firmness and laxity of the skin and its sag. A decrease in the volume, surface and depth of skin deformation corresponds to an increase in skin firmness.
- Table 2 The data pertaining to volume, surface, and maximum depth improvements after use of the composition according to Example 1 are presented in Table 2.
- Moisturization/hydration data was obtained using a Corneometer®, which measures capacitance of the skin, which corresponds to the humidity level of the measured skin. An increase in Corneometer® value corresponds therefore to a desired increase in moisturization/hydration.
- the data pertaining to skin-moisturization are presented below in Table 3.
- Table 3 demonstrate the skin-moisturizing benefits of the natural skincare composition according to Example 1. Test subjects experienced a 19% increase in skin moisture after 28 days, a 36% increase after 56 days, and a 52% increase after 84 days, with 100% of test subjects experiencing the increase at 84 days.
- the anti-aging effect of the composition was determined using a high-frequency echograph Dermascan® C 2D instrument which measures combined dermis and epidermis thickness.
- the device emits an ultrasound beam that generates a two-dimensional image of the dermis and epidermis used to measure the thickness of the skin.
- an increase in thickness between the epidermis and the dermo-hypodermis junction corresponds to a positive anti-aging effect.
- the data corresponding to the measurement are presented below in Table 4.
- the natural skincare composition according to Example 1 has substantial anti-aging effects including a thicker epidermis-dermis after 28, 56, and 84 days of use, with 85% of test subjects showing a 6% increase in thickness after 84 days.
- SquameScan® software in conjunction with D-Squame® tape strips. This tool is designed to measure IR-light absorption and thereby determine stratum-corneum protein content on the D-Squame® strip. A decrease in light absorption corresponds to a decrease in the amount of protein detected, thus evidencing that the skin has experienced a desirable skin restructuring effect. The data from this measurement are provided below in Table 5.
- Example 1 The above-discussed in-vivo clinical testing clearly and quantitatively establishes, the significant impact on skin health and appearance achieved by the use the inventive composition of Example 1, with benefits such as smoother, less-wrinkled, firmer, more-moisturized, thicker, and restructured skin.
- test subjects were then asked to assess, qualitatively, their impression of the composition of Example 1 with respect to its sensorial qualities in general and its efficacy after 56 and 84 days of use.
- the test subjects all appreciated the sensorial qualities of the product with regards to its texture, color, ease of application, and non-greasy/non-sticky feel on their skin.
- their perception of the product's efficacy they all believed that after 56, and especially 84 days of use their skin was more moisturized, nourished, comfortable, smooth, elastic, firm, dense, brightened/luminous, re-tightened, detoxified, healthy and more uniform in appearance.
- the efficacy of a skincare composition according to embodiments of the present disclosure and incorporated into different cosmetic products was measured against a leading cosmetic product.
- Five cosmetic products incorporating the skincare composition including a face, hands, and body cream, an exfoliating wash, an eye gel cream, a day cream, and a facial oil, were measured against the leading cosmetic product, a day cream, using quantifiable metrics as described herein.
- Each of the users who participated in the study were instructed to wash their face for a one-week period using Cetaphil® Gentle Skin Cleanser prior to the study and to refrain from using any anti-aging treatments/products during the washout period and for the duration of the study.
- the five cosmetic products incorporating the skincare composition according to embodiments of the disclosure and the leading cosmetic product were assessed using one or more quantifiable metrics such as a Corneometer® measurement, a Tewameter® measurement, Image Pro® software, a D-Squame® measurement, a Sebumeter® measurement, and a Cutometer® measurement.
- quantifiable metrics such as a Corneometer® measurement, a Tewameter® measurement, Image Pro® software, a D-Squame® measurement, a Sebumeter® measurement, and a Cutometer® measurement.
- moisturization/hydration data was obtained using a Corneometer®, which measures capacitance of the skin, which corresponds to the humidity level of the measured skin. Since water is known to be an excellent conductor of electricity, an increase in electrical conductance corresponds to an increase in skin's hydration/moisture levels. An increase in Corneometer® value corresponds therefore to a desired increase in moisturization/hydration.
- SquameScan® software was used in conjunction with D-Squame® tape strips to measure IR-light absorption and thereby determine stratum-corneum protein content on the D-Squame® strip. This measures the ability of the skin's outermost layer to effectively protect the body from external factors light sunlight and pollution, as well as retain moisture to prevent it from becoming dry, and is determined by the amount of particular skin proteins found in this layer. Specially designed tape is first applied onto the skin to remove dead skin cells from the surface, at which point the amount of protein in the cells is measured. A decrease in light absorption corresponds to a decrease in the amount of protein detected, thus evidencing that the skin has experienced a desirable skin restructuring effect.
- Transepidermal water loss was evaluated using a Tewameter®, such as is available from Courage+Khazaka electronic GmbH of City, Germany, or alternatively by a VapoMeter from Delfin Technologies of Kuopio, Finland.
- This device measures skin's ability to retain water. When water passes through the skin, which is a natural biological process, and evaporates from the skin's surface, this phenomenon is referred to as TEWL and is a measure of skin's ability to retain moisture present in the dermis. If the skin's ability to retain moisture is enhanced after use of a product, its effectiveness as a moisturizer is confirmed.
- Oil content on the skin was measured using a Sebumeter®, also of Courage+Khazaka electronic GmbH.
- the Sebumeter® evaluates the effectiveness of a product intended to reduce oil content on the skin by grease-spot photometry, in which the tape of the device contacts a user's skin and is then measured by a photocell.
- Cutometer® Skin elasticity was measured using a Cutometer® available also from Courage+Khazaka electronic GmbH.
- the Cutometer® uses a suction method in which negative pressure mechanically deforms the skin. Skin is withdrawn into an aperture of a probe for a defined time, and measured using a non-contact optical measuring system. The resistance of the skin to the negative pressure represents firmness and its ability to return to its original position represents elasticity. Accordingly, a decrease in Cutometer® measurements indicates an improvement in skin firmness.
- the face, hands, and body cream used in the study comprises (1) a preservative system comprising: (a) from about 2 to about 4% by weight, of a Lactobacillus ferment; (b) from about 2 to about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) from about 0.2 to about 0.4% by weight, of salicylic acid; (d) from about 0.2 to about 0.4% by weight, of at least one salt of a weak acid, preferably potassium sorbate; and (e) from about 4 to about 6% by weight, of a petroleum-free propanediol; (2) a moisturizing/hydrating-effective amount of a mixture of at least: (f) an oil infusion of Calendula officinalis having about 0.5% by weight of Calendula officinalis extract, and about 2% by weight of almond oil; (g) an oil infusion of Helichrysum italicum having about 1.2% by weight, of Helichrysum italicum extract, and about 4.7%
- the combination of Calendula officinalis, Helichrysum italicum, Symphytum officinale, Viola tricolor , and at least one Mallow extract beneficially provides synergistic effects on the skin, including moisturizing the skin, protecting the skin with a film, shedding dry outer layers of the epidermis, improving osmotic function, and providing a soothing gel, as described above.
- the exfoliating wash used in the study comprises a skincare composition comprises (1) a preservative system comprising (a) from about 2 to about 4% by weight, of a Lactobacillus ferment; (b) from about 2 to about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) from about 0.2 to about 0.4% by weight, of salicylic acid; (d) from about 0.2 to about 0.4% by weight, of at least one salt of a weak acid, preferably potassium sorbate; and (e) from about 4 to about 6% by weight, of a petroleum-free propanediol; (2) at least one of an Elderflower hydrosol; infusions of Milk Thistle oil; Castor oil; Safflower oil; Grapefruit essential oil; and jojoba beads; and (3) a dermatologically acceptable emulsifier, and has a pH ranging from about 4.5 to about 5.5, preferably from about 4.8 to about 5.3.
- This combination of ingredients advantageously provides synergistic effects that gently
- the eye gel cream used in the study comprises a skincare composition comprises (1) a preservative system comprising (a) from about 2 to about 4% by weight, of a Lactobacillus ferment; (b) from about 2 to about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) from about 0.2 to about 0.4% by weight, of salicylic acid; (d) from about 0.2 to about 0.4% by weight, of at least one salt of a weak acid, preferably potassium sorbate; and (e) from about 4 to about 6% by weight, of a petroleum-free propanediol; (2) at least one of Helichrysum italicum ; cucumber; aloe vera; and infusions of Arnica oil and Bladder Wrack oil; and (3) a dermatologically acceptable emulsifier, and has a pH ranging from about 4.5 to about 5.5, preferably from about 4.8 to about 5.3.
- a preservative system comprising (a) from about 2 to about 4% by
- This combination of ingredients advantageously reduces puffiness around the eyes, reduces irritation and moisture loss, hydrates the skin by providing a moisture-retentive film, provides amino acids, proteins and lipids that plump and calm the skin, and soothes and hydrates the skin while increasing firmness.
- the day cream used in the study comprises a skincare composition
- a skincare composition comprises (1) a preservative system comprising (a) from about 2 to about 4% by weight, of a Lactobacillus ferment; (b) from about 2 to about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) from about 0.2 to about 0.4% by weight, of salicylic acid; (d) from about 0.2 to about 0.4% by weight, of at least one salt of a weak acid, preferably potassium sorbate; and (e) from about 4 to about 6% by weight, of a petroleum-free propanediol; (2) at least one of Calendula -infused oil and water; Serrated Wrack; Hyaluronic acid from about 1 to about 3% by weight; Sweet Almond oil; and Green Mandarin oil; and (3) a dermatologically acceptable emulsifier, and has a pH ranging from about 4.5 to about 5.5, preferably from about 4.8 to about 5.3.
- This combination of ingredients advantageously improves skin distensibility, firmness, and viscoelasticity, improves skin suppleness and elasticity by moisturizing and improving the skin barrier, boosts the skin's ability to absorb moisture resulting in smoother, softer skin, and tones and balances oil production of the skin.
- the facial oil used in the study comprises a skincare composition
- a skincare composition comprises (1) a preservative system comprising (a) from about 2 to about 4% by weight, of a Lactobacillus ferment; (b) from about 2 to about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) from about 0.2 to about 0.4% by weight, of salicylic acid; (d) from about 0.2 to about 0.4% by weight, of at least one salt of a weak acid, preferably potassium sorbate; and (e) from about 4 to about 6% by weight, of a petroleum-free propanediol; (2) at least one of Rosehip oil; Bog Myrtle; Sea Buckthorn; Prickly Pear Seed oil; Serrated Wrack; Rosemary; Kiwi Seed oil; and Baobab oil; and (3) a dermatologically acceptable emulsifier, and has a pH ranging from about 4.5 to about 5.5, preferably from about 4.8 to about 5.3.
- This combination of ingredients advantageously smoothes, moisturizes, and softens the skin, providing vitamins A, C, D, E, and K and essential fatty acids, cleans the pores, provides antioxidants, retains moisture and improves skin elasticity and suppleness, reduces hyperpigmentation, protects the skin from environmental stressors, controls sebum production, and maintains clear skin.
- cosmetic products and listed ingredients are merely exemplary and may further comprise any necessary components such as emulsifiers, fragrances, natural preservatives, and other ingredients within any suitable proportion.
- the leading dermatological product used as a benchmark is a moisturizing cream comprising conventional dermatological ingredients, as well as hyaluronic acid, dimethicone, and ceramides.
- the skincare compositions according to the disclosure universally achieve an improvement in skin hydration for all or a large majority of users, with the facial oil comprising the skincare composition achieving an especially marked improvement relative to baseline hydration and relative to the leading dermatological product.
- TEWL transepidermal water loss
- the skincare compositions of the disclosure as embodied in four of the five skincare products achieve universally an improvement in skin barrier function relative to baseline by day 28, and with the exception of the Day Cream product achieve a larger improvement for a larger percentage of users than the leading dermatological product.
- Visia CR® was used to generate a texture score for the skin based on the mean intensities of the red, green, and blue pixels of the captured images.
- a decrease in the texture score calculated according to this method represents an improvement in overall skin texture.
- Under-eye puffiness is determined in a similar manner.
- Under-eye discoloration was measured by assessing chroma. The degree to which a color is free from being mixed with other colors indicates its chromaticity. An increase in chromaticity represents an improvement in under-eye discoloration.
- the use of skincare compositions according to the disclosure advantageously improves skin texture relative to the leading dermatological product, and in most cases for a larger number of users.
- the use of skincare compositions according to the present disclosure advantageously improve a user's under-eye puffiness, particularly after 14 days, in which period the improvement is more substantial and observed over a larger percentage of users than for the leading dermatological product.
- the use of skincare compositions according to the present disclosure advantageously improve a user's under-eye discoloration compared to the leading dermatological product and for a larger percentage of users.
- a Sebumeter® was used to measure facial sebum/oil levels of users using the leading dermatological product, the facial oil, and the exfoliating wash. The results are shown in Table 11 below, wherein a negative value represents an improvement.
- the skincare compositions according to the disclosure advantageously improve a user's facial sebum/oil levels compared to baseline and to a greater degree and for a greater percentage of users than the leading dermatological product, particularly when used in the facial oil product.
- the skincare compositions of the disclosure advantageously improve universally skin flakiness relative to baseline, and certain of the disclosed embodiments show greater improvement for a higher percentage of users than the leading dermatological product.
- the users' skin firmness was also measured using a Cutometer® and assessed for both the leading dermatological product and the facial oil product, the results of which are shown in Table 13 below. A negative value indicates an improvement to skin firmness.
- the use of skincare compositions according to the disclosure advantageously improves a user's skin firmness relative to baseline.
- the composition comprising a combination of natural botanical ingredients such as Calendula officinalis, Helichrysum italicum, Symphytum officinale, Viola tricolor , and Mallow moisturizes, soothes, and nourishes the skin by providing a protective film and gel on the skin, helping the skin shed the dry outer layers of the epidermis and by improving osmotic function to better retain water while avoiding the undesirable complications of synthetic and/or petroleum-based moisturizers.
- the compositions may further be combined with an all-natural preservative system that improves the chemical stability and shelf-life of the composition without using harsh, irritating synthetic preservatives.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
- The disclosure relates to compositions and methods of enhancing the health and appearance of human skin using botanical ingredients, and more particularly to moisturizing compositions, preservatives therefor, and methods of using the same.
- Skin is subjected to numerous extrinsic and intrinsic negative influences that affect its appearance, physical properties and physiological functions. Extrinsic influences include ultraviolet radiation, environmental pollution, extreme temperatures, harsh surfactants, contamination from consumer products, oxidative stress, and mechanical stress caused by, for example, shaving, abrasions, and the like. Intrinsic influences include chronological aging, a person's genetic makeup, skin homogeneity, skin-barrier function, thickness of the skin layer, degradation of the extracellular matrix, the activity level of particular genes, nuclear cell function, and other biological changes, such as scarring, that occur from within the skin. Regardless of the specific cause, these factors result in the development of fine lines and wrinkles, sagging, and loss of elasticity and firmness, which are oftentimes associated with an attendant reduction in the skin's moisture content.
- As the body's largest organ, skin holds in fluids and prevents dehydration. Consequently, it is important to the health and appearance of skin to keep it nourished in order to help counteract the damage caused by the above-referenced extrinsic and intrinsic influences. Dry skin is a particularly common disorder that affects both males and females equally, and is particularly prevalent in older individuals and those genetically predisposed to such a condition. People suffering from dry skin complain of flaking, itching, irritation, and an overall dull, rough and lackluster appearance to their skin. Moreover, as a person ages, their skin tends to produce fewer natural oils that aid in preventing moisture from escaping from the skin, and as a result older individuals are more prone to dehydration.
- To counteract the negative impact of these extrinsic and intrinsic influences on skin, treatments such as topical therapy, oral therapy, cosmetic procedures and compositions, nutrition and dietary practices, injections, disruptive lifestyle adjustments, and UV therapy have been developed. Unfortunately, these treatments oftentimes suffer from drawbacks associated with skin irritation and/or prolonged recovery periods. Many cosmetic compositions include synthetic, harsh, petroleum-based, and/or carcinogenic or otherwise harmful ingredients as moisturizers or preservatives because of their low cost and/or efficacy.
- For example, a moisturizing composition commonly contains emollients, preservatives, fragrances, and emulsifiers to hold the composition's ingredients together. Any or all of these categories of ingredients may contain synthetic and/or petroleum-based ingredients. For example, the emollient which aids in retaining moisture in the skin may be formed from petroleum and/or synthetic alcohols and may form a waterproof barrier on the skin. In some instances, such synthetic emollients are known to cause irritation or harm to the skin, to not soothe or provide necessary nutrients to the skin, and to be ineffective at moisturizing the skin, particularly over time. Synthetic emollients that are excessively occlusive, such that moisture is trapped against the skin, can interfere with normal skin function. Synthetic preservatives such as phenoxyethanol, parabens, formaldehyde donors, and other compounds can cause skin irritation and other serious health issues. Synthetic fragrances may likewise cause skin irritation and may be toxic. Non-plant-based emulsifiers usually comprise petroleum derivatives.
- The use of such ingredients—and the deleterious effects associated therewith—has led to a demand for effective, all-natural cosmetic compositions that include ingredients such as moisturizers, preservatives, and other ingredients while omitting synthetic, petroleum-based, harsh, and/or harmful ingredients.
- In response to the outstanding need in the industry for products that meet certain thresholds of “natural” and “organic” ingredients, coupled with the lack of official standards for what qualifies as “natural” and “organic,” preservative formulation has become a cottage industry with consumers gravitating towards products containing natural extracts, botanicals, or other ingredients derived from natural sources, while avoiding those products having ingredients that are either known to cause or suspected of causing adverse health reactions. Unfortunately, this ad hoc approach and decentralization of acquired knowledge and experience of generating effective preservative formulations has led to a host of ineffective solutions that typically result in diminished shelf-life and usability of associated topical consumer products.
- Various third-party certifications have been established in an attempt to bring consistency and reliability to the use of natural and organic preservatives in topical consumer products. For example, ECOCERT® is an organic certification organization based in Europe that conducts inspections in over 80 countries, making it one of the largest organic certification organizations in the world. ECOCERT® primarily certifies food and food products but also certifies cosmetics, detergents, perfumes, and textiles and is a leading certifier of fair-trade food, cosmetics, and textiles.
- Another example is the Cosmetic Organic Standard (COSMOS), a Europe-wide private standard that was developed by five charter members: BDIH (Germany), Cosmebio (France), Ecocert Greenlife SAS (France), ICEA (Italy), and Soil Association (Great Britain). They were all combined under AISBL (international non-profit organization based in Brussels), the purpose of which was to set out minimum common requirements, harmonize organic and natural cosmetic certification rules, and lobby institutions in the sector's interests. COSMOS makes use of the principles in the ECOCERT® standard: to promote the use of ingredients from organic farming, use production and manufacturing processes that are environmentally sound and safe for human health, and include and expand the concept of “green chemicals.”
- The National Organic Program (NOP), a federal regulatory framework in the United States governing organic food, is yet another certification. The core mission of the NOP is to protect the integrity of the United States Department of Agriculture (USDA) organic seal. The seal is used for products adhering to USDA standards that contain at least 95% organic ingredients.
- Yet despite the upwelling demand and need for all-natural cosmetic compositions and despite the certification systems pressuring the market to identify systems as such, existing efforts have had difficulty identifying natural cosmetic compositions that omit undesired ingredients without compromising on effective preservation, moisturizing, or other desired features.
- The use of botanical extracts on the skin, and existing attempts to provide natural or plant-based moisturizers and other cosmetics, are limited to, on the one hand, highly limited and narrow descriptions of particularized treatments, such as eczema and psoriasis, and, on the other hand, highly generalized descriptions of botanical extracts that lack helpful instructions on how to actually formulate a skin-treatment product that is stable and effective and which omits harmful ingredients. For example, U.S. Pat. No. 4,933,177 to L'Oreal of Paris, France discusses the use of certain botanical ingredients in skincare, but does not teach or suggest the precise association of ingredients, extraction techniques, and solvents to be used, and ingredients to avoid, to provide an efficacious all-natural product capable of enhancing skin health and appearance.
- Because of the number of botanical extracts, solvents, and extraction techniques, a prohibitively large number of possible cosmetic compositions can be conceived. But one cannot merely combine a mixture of random botanical extracts, in arbitrary concentrations, using arbitrary extraction techniques and solvents, with any expectation of successfully formulating a product with intended benefits and properties.
- Further, when considering the currently available “all natural” skincare compositions, the reproducibility and scientific rigor of any alleged benefits are of particular concern. This challenge is illustrated by the aforementioned “cottage industry” of do-it-yourself (“DIY”) cosmeticians that have arisen on the internet, encouraging others to create their own cosmetic formulations having unsubstantiated benefits. Instructions are provided on how to make, for example, a nourishing face mask from ground oats, honey, and egg yolks; a three-ingredient moisturizer consisting of coconut oil mixed with lavender and tea-tree essential oils; an “all-natural” deodorant consisting of baking soda, starch, and coconut oil; and countless others. Such combinations may indeed be plant-based and free of synthetic ingredients, but credible and reproducible data demonstrating the efficacy and benefits of such combinations, and a demonstrated understanding of the chemical and biological mechanisms at play, are nowhere to be found.
- Another major deterrent associated with the use of botanical ingredients in skincare compositions relates to their relative instability in products. This is evidenced by loss of potency, odor deviations, and discoloration that plague existing “all-natural” formulations. These negative attributes increase the risk of microbial contamination and proliferation, chemical instability, and safety of the products.
- In view of the foregoing, there is not an all-natural cosmetic product such as a moisturizer that effectively improves skin health by, for example, properly retaining moisture while omitting synthetic or harmful additives, and that is demonstrated by reproducible and consistent benefits according to credible scientific standards and certifications. Accordingly, there is a need for an all-natural cosmetic product that provides effective skincare using only all-natural ingredients.
- The problem of existing cosmetic compositions including harmful, synthetic, and/or petroleum-based additives, and the problem of existing “all-natural” cosmetic compositions, including moisturizers, lacking rigorous evidence demonstrating their efficacy, is addressed by embodiments of a skincare composition and method of treatment according to the present disclosure.
- Embodiments of the present disclosure are directed to a skincare composition intended for enhancing skin health and appearance and containing: (1) a moisturizing/hydrating-effective amount of a mixture of at least: (a) an oil infusion of Calendula officinalis extract; (b) an oil infusion of Helichrysum italicum extract; (c) an oil infusion of Symphytum officinale extract; (d) an aqueous infusion of Viola tricolor extract; and (e) an aqueous infusion of at least one Mallow extract, such as and/or selected from Althea officinalis and/or Malva sylvestris; and (2) an emulsifying-effective amount of a dermatologically acceptable emulsifier, wherein the composition is all-natural and free of a skin sensitizing-effective amount of a volatile essential oil.
- According to another embodiment, the present disclosure is also directed to a skincare composition intended for enhancing skin health and appearance containing: (1) a natural preservative system; (2) a moisturizing/hydrating-effective amount of a mixture of at least: (a) an oil infusion of Calendula officinalis extract; (b) an oil infusion of Helichrysum italicum extract; (c) an oil infusion of Symphytum officinale extract; (d) an aqueous infusion of Viola tricolor extract; and (e) an aqueous infusion of at least one Mallow extract, such as and/or selected from Althea officinalis and/or Malva sylvestris; and (3) an emulsifying-effective amount of a dermatologically acceptable emulsifier, wherein the composition is natural and free of a skin sensitizing-effective amount of a volatile essential oil.
- According to further embodiments, the present disclosure is also directed to a skincare composition intended for enhancing skin health and appearance comprising a moisturizing/hydrating-effective amount of a mixture of (1) a natural preservative system; and (2) at least one of an Elderflower hydrosol, infusions of Milk Thistle oil, Castor oil, Safflower oil, and Grapefruit essential oil, and jojoba beads.
- According to further embodiments, the present disclosure is also directed to a skincare composition intended for enhancing skin health and appearance comprising a moisturizing/hydrating-effective amount of a mixture of (1) a natural preservative system; and (2) at least one of cucumber, aloe vera, and infusions of Arnica oil and Bladder Wrack oil.
- According to further embodiments, the present disclosure is also directed to a skincare composition intended for enhancing skin health and appearance comprising a moisturizing/hydrating-effective amount of a mixture of (1) a natural preservative system; and (2) at least one of Calendula-infused oil and water, Serrated Wrack; Hyaluronic acid; Sweet Almond oil; and Green Mandarin oil.
- According to further embodiments, the present disclosure is also directed to a skincare composition intended for enhancing skin health and appearance comprising a moisturizing/hydrating-effective amount of a mixture of (1) a natural preservative system; and (2) at least one of Rosehip oil, Bog Myrtle, Sea Buckthorn, Prickly Pear Seed oil, Serrated Wrack, Rosemary, Kiwi Seed oil, and Baobab oil.
- The present disclosure is also directed to a method of enhancing skin health and appearance by applying one of the above-disclosed skincare compositions onto the skin.
- According to yet another embodiment, the present disclosure is also directed to a method of treating compromised skin by applying one of the above-disclosed skincare compositions onto the skin.
- These and other features, aspects and advantages of the present disclosure will become evident to those skilled in the art from a reading of the present disclosure.
- For purposes of the present disclosure, the use of the word “natural” is intended to encompass ECOCERT®-approved ingredients or formulations synonymous with the terms “green,” “clean,” “organic,” “sustainable,” “eco-friendly,” or “environmentally-friendly” as known and used in the art. The term “natural,” for example, may be used in the context of holistic or homeopathic formulations and is intended to include those topical consumer products and/or preservative systems that are plant-based, paraben-free, and/or non-toxic.
- Further, when used in the context of the antimicrobial properties of a preservative or a preservative system, the term “broad spectrum” is intended to describe those preservatives or preservative systems of the present disclosure that have the ability to inhibit the growth of or kill a wide range of microorganisms that decay or spoil topical consumer products. For example, a “broad spectrum” preservative system inhibits the growth of or kills a wide range of bacteria and fungi, preferably a wide range of Gram-positive and Gram-negative bacteria, yeasts, molds, and/or other fungi.
- The compositions of the present invention can comprise, consist essentially of, or consist of, the components of the present invention as well as other ingredients described herein. The term “comprising” as used herein is meant to include various optional, compatible components that can be used in the preservative systems and cosmetic compositions of the present disclosure. The term “consisting essentially of” as used herein means that the composition or component may include additional ingredients, but only if the additional ingredients do not materially alter the basic and novel characteristics of the compositions or methods.
- As used herein, the words “preferred”, “preferably” and variants thereof refer to embodiments of the disclosure that afford certain benefits under certain circumstances. However, other embodiments may also be preferred under the same or other circumstances. Furthermore, the recitation of one or more preferred embodiments does not imply that other embodiments are not useful and is not intended to exclude other embodiments from the scope of the disclosure.
- Numerical ranges as used herein are intended to include every number and subset of numbers contained within that range, whether specifically disclosed or not. Further, these numerical ranges should be construed as providing support for a claim directed to any number or subset of numbers within that range.
- All percentages, parts, proportions, and ratios as used herein are by weight of the total composition, unless otherwise specified. All such weights as they pertain to listed ingredients are based on the active level.
- All references to singular characteristics or limitations of the present disclosure shall include the corresponding plural characteristic or limitation, and vice-versa, unless otherwise specified or clearly implied to the contrary by the context in which the reference is made.
- All publications, articles, papers, patents, patent publications and other references cited herein are hereby incorporated in their entireties for all purposes to the extent consistent with the disclosure herein.
- The term “compromised skin” as described herein means skin that suffers from symptoms such as dryness, flakiness, itchiness, and irritation. Compromised skin can be caused by extrinsic and/or intrinsic influences, as noted above. Extrinsic influences include, in addition to the influences discussed previously, sunburn, pollution, use of hard-surface cleaning products having harsh chemicals, and mechanical stress associated with shaving and certain dermatological procedures such as laser, microdermabrasion, micro-needling or chemical peel therapy. Intrinsic influences include, in addition to the influences discussed previously, conditions such as eczema and dermatitis. The use of a topical product can effectively moisturize/hydrate the skin in response to such intrinsic influences, thereby alleviating some of the pain and discomfort experienced by individuals suffering from the above-referenced symptoms.
- The term “skin-sensitizing effective amount” as described herein is meant to describe an amount of a volatile essential oil that can lead to an allergic response following contact with an individual's skin. Skin sensitization is an immunological response to previous exposure to a substance that results in an inflammatory skin reaction. An allergic skin reaction is usually presented as a red, itchy, bumpy rash. Examples of the types of volatile essential oils that can cause skin sensitization, depending on their amounts within a skincare composition include, but are not limited to, frankincense, myrrh, and sweet orange.
- The present disclosure generally relates to a skincare composition that not only effectively enhances skin health and appearance when topically applied thereon, but also serves to help alleviate symptoms associated with compromised skin. Moreover, the skincare composition is also natural, organic and ECOCERT®-approved, thus being free of harmful synthetic and/or petroleum-derived ingredients.
- It has surprisingly been discovered by the inventors that a skincare composition that is both all-natural and free of skin-sensitizing ingredients, containing a mixture of specific botanical infusions comprised of at least: an oil infusion of Calendula officinalis extract; an oil infusion of Helichrysum italicum extract; an oil infusion of Symphytum officinale extract; an aqueous infusion of Viola tricolor extract; and an aqueous infusion of at least one Mallow extract, such as or selected from Althea officinalis and/or Malva sylvestris, when applied onto skin, both moisturizes and hydrates the skin, and helps the skin retain/lock-in this moisture, thereby enhancing both its health and appearance and, if the skin is also compromised, helps to alleviate symptoms associated therewith.
- Calendula officinalis extract is derived from the common marigold plant. Common bioactive compounds found therein include, for example, flavonoids, phenolic acids, carotenoids, triterpenic alcohols, polycarbohydrates, proteins, amino acids, saturated hydrocarbons, vitamin C, and mineral substances.
- The Calendula officinalis extract of the present disclosure is preferably employed in an amount of from about 0.3 to about 0.6% by weight, and most preferably in an amount of about 0.5% by weight, all weights based on the total weight of the skincare composition. The Calendula officinalis extract is employed in the form of an oil infusion. The oil component of the infusion is preferably employed in an amount of from about 1 to about 3% by weight, and most preferably in an amount of about 2% by weight, based on the total weight of the composition.
- Calendula officinalis beneficially brings moisturizing and soothing properties to dry or irritated skin, thereby helping to protect the skin. Calendula officinalis stimulates physiological healing and regeneration of wounded skin and aids the skin in retaining hydration. In particular, Calendula officinalis improves skin distensibility, firmness, and viscoelasticity, in part by increasing blood flow to the area of application and encouraging tissue regeneration.
- Helichrysum italicum extract contains numerous bioactive compounds including, for example, phenolics such as heterodimeric phloroglucinyl pyrone arzanol, angeloylated glycerides known as santinols, coumarates, benzofurans, pyrones, and heterodimeric phloroglucinols.
- The Helichrysum italicum extract of the present disclosure is preferably employed in an amount of from about 0.9 to about 1.3% by weight, and most preferably in an amount of about 1.2% by weight, all weights based on the total weight of the skincare composition. The Helichrysum italicum extract is employed in the form of an oil infusion. The oil component of the infusion is preferably employed in an amount of from about 4 to about 7% by weight, and most preferably in an amount of about 4.7% by weight, based on the total weight of the composition.
- Helichrysum italicum has emollient properties and creates a protective film to retain moisture and keep the skin hydrated.
- The primary bioactive compounds found in Symphytum officinale extract include allantoin, rosmarinic acid and ellagic acid.
- The Symphytum officinale extract of the present disclosure is preferably employed in an amount of from about 0.3 to about 0.6% by weight, and most preferably in an amount of about 0.5% by weight, all weights based on the total weight of the skincare composition. The Symphytum officinale extract is employed in the form of an oil infusion. The oil component of the infusion is preferably employed in an amount of from about 1 to about 3% by weight, and most preferably in an amount of about 2% by weight, based on the total weight of the composition.
- Symphytum officinale provides keratolytic properties to shed dry, outer layers of the epidermis, thereby helping to maintain a healthy level of moisture and an improved appearance of the skin.
- While any vegetable oil may be used as the oil component in the above-described oil infusions so long as it does not cause skin sensitization, a particularly preferred oil component is almond oil. The inventors have surprisingly discovered that the use of almond oil enables bioactive compounds present in the oil infusions to effectively penetrate into the skin, without the need to use skin-sensitizing essential oils, and while still facilitating the desired degree of efficacy in terms of skin health and appearance resulting from enhanced moisturization and hydration of the skin. This is due to almond oil being rich in beta-zoosterol, squalene, and alpha-tocopherol, together with smaller amounts of carbohydrates, proteins, vitamins, and minerals such as vitamin B complex and zinc. Almond oil's phytochemicals are believed to be effective at promoting surface-level proliferation and skin cell development. Other vegetable oils that may be used include, but are not limited to, olive oil, jojoba oil, babassu oil, caster oil, coconut oil, corn oil, cotton seed oil, linseed oil, mustard oil, safflower oil, sesame oil, soybean oil, sunflower-seed oil, wheat germ oil, argan oil and manila oil.
- Some interesting bioactive compounds found in Viola tricolor extract include small peptides known as cyclotides, flavonoids such as quercetin, luteolin and rutin, mucilages consisting of glucose, galactose, arabinose and rhamnose, as well as tannins and salicylic acid and its derivatives.
- The Viola tricolor extract of the present disclosure is preferably employed in an amount of from about 2 to about 3% by weight, and most preferably in an amount of about 2.5% by weight, all weights based on the total weight of the composition. The Viola tricolor extract is employed in the form of an aqueous infusion.
- Viola tricolor advantageously provides polysaccharides to boost the skin's capacity to retain water by improving osmotic function.
- The at least one Mallow extract of the present disclosure will preferably be chosen from Malva sylvestris extract and Althea officinalis extract. These Mallow extracts possess an abundance of mucilages having polysaccharides contained therein. These mucilages consist mainly of glucuronic acid, galacturonic acid, rhamnose, galactose, fructose, glucose, sucrose and trehalose, as well as lesser amounts of uronic acid, arabinose, mannose, xylose, fucose, raffinose and 2-O-α-(4-O-methyl-α-d-glucuronosyl)-xylotriose.
- The at least one Mallow extract of the present disclosure is preferably employed in an amount of from about 2 to about 3% by weight, and most preferably in an amount of about 2.5% by weight, all weights based on the total weight of the skincare composition. A particularly preferred Mallow extract is Althea officinalis extract. The Mallow extract is employed in the form of an aqueous infusion.
- The at least one Mallow extract forms a soothing protective gel that moisturizes dry, rough skin due to its mucilaginous properties, which form a thick, gluey substance.
- Both the Viola tricolor and Mallow extracts are employed as aqueous infusions, wherein the total water content of both aqueous infusions is from about 50 to about 70% by weight, and preferably about 60% by weight, all weights based on the total weight of the skincare composition.
- By providing a skincare composition comprising a combination of Calendula officinalis, Helichrysum italicum, and Symphytum officinale oil infusions and Viola tricolor and Mallow aqueous extracts, the skincare composition hydrates, soothes, and nourishes a user's skin in complementary ways. The skincare composition soothes the skin with Calendula officinalis, creates a protective moisture-retaining film with Helichrysum italicum, helps the skin shed dry outer layers of epidermis with Symphytum officinale, improves osmotic function with Viola tricolor, and forms a moisturizing and soothing protective gel with Mallow extract. The skincare composition's combination of botanical oil infusions with botanical aqueous extracts, held together by a natural and dermatologically favorable emulsifier, avoids the problem created by synthetic and petroleum-based moisturizers, which are oppressively occlusive and interfere with normal skin function. The skincare composition benefits normal skin function by providing healing and/or nourishing compounds to protect the skin across a range of physiological functions, including shedding of dry epidermis layers, improving moisture retention, and forming natural protective films and gels to augment and supplement the skin's biological moisturizing properties.
- Calendula officinalis, Helichrysum italicum, Symphytum officinale, Viola tricolor, and Mallow are further provided in specific, effective, synergistic, and targeted amounts for user health, comfort, cost, and compatibility. Moreover, as discussed in greater detail herein, the benefits and efficacy of the composition are quantifiable, reproducible, and rigorously obtained.
- The botanical oil infusions of the present disclosure are obtained using an extraction technique known as maceration. This technique, typically performed at room temperature, involves immersing a plant in oil which functions as a solvent inside an airtight vessel for a variable amount of time based on the plant material being infused into the oil.
- The vessel in which the plant material is being macerated is periodically agitated in order to aid the solvent in penetrating the outer cell walls of the plant material. Once the plant material has been sufficiently infused with the solvent, the resultant macerated product is then filtered in order to separate the residual plant material from the liquid. The residual plant material is then pressed in order to recover any excess liquid entrapped therein.
- The botanical aqueous infusions of the present disclosure are obtained using an extraction technique known as decoction. This technique involves immersing a plant in boiling water, preferably purified water, inside an airtight vessel, for a variable amount of time based on the plant material being infused into the water.
- Prior to being processed, the plant is first properly washed and separated from any foreign material such as topsoil, pebbles or rocks, weeds, and other materials not suitable for extraction. The plant material should be used fresh in order to maintain the integrity of the bioactive components in the fresh plant matter. The use of dried plant material is typically not desirable due to the degradation experienced by the plant during the dehydration process. During dehydration, the cell walls are compromised resulting in the degradation of compounds through mechanisms such as hydrolysis, oxidation, polymerization, Maillard reactions, and isomerization. When the dried plant undergoes extraction, the resulting extract contains these degradation products that were not in the fresh plant matter. The presence of these degradation products can negatively impact the efficacy of the product and increase the potential for skin sensitization.
- In order to maximize the contact between the plant material to be macerated and the oil, the plant is preferably cut into small pieces. The pieces should not be too big, otherwise the oil will not be able to penetrate the plant's innermost cells. The pieces should also not be reduced to powder, as that would make it more difficult to separate the infusion from the bulk plant material via filtration once the maceration process is completed.
- Because the skincare composition of the present disclosure comprises a mixture of both oil infusions and aqueous infusions, an emulsifier should also be employed in order to emulsify the immiscible oil and aqueous phases of the skincare composition. Any ingredient capable of emulsifying the composition may be employed without departing from the spirit of the disclosure so long as it is natural and dermatologically acceptable. Suitable emulsifiers include, but are not limited to, glyceryl stearate, cetyl alcohol, sodium stearoyl lactylate, sorbitan olivate, cetearyl olivate, cetearyl alcohol, cetearyl glucoside, sodium cetearyl sulfate, and the like. It is also particularly preferred that the emulsifier be free of palm oil.
- According to one embodiment of the present disclosure, there is provided a skincare composition for application onto human skin in order to enhance its health and appearance, the composition containing a moisturizing/hydrating-effective amount of a mixture of at least: (a) an oil infusion of Calendula officinalis having from about 0.3 to about 0.6% by weight, and preferably about 0.5% by weight, of Calendula officinalis extract, and from about 1 to about 3% by weight, and preferably about 2% by weight of a vegetable oil, preferably almond oil; (b) an oil infusion of Helichrysum italicum having from about 0.9 to about 1.3% by weight, and preferably about 1.2% by weight, of Helichrysum italicum extract, and from about 4 to about 7% by weight, and preferably about 4.7% by weight of a vegetable oil, preferably almond oil; (c) an oil infusion of Symphytum officinale having from about 0.3 to about 0.6% by weight, and preferably about 0.5% by weight, of Symphytum officinale extract, and from about 1 to about 3% by weight, and preferably about 2% by weight, of a vegetable oil, preferably almond oil; (d) an aqueous infusion of Viola tricolor having from about 2 to about 3% by weight, and preferably about 2.5% by weight, of Viola tricolor extract; and (e) an aqueous infusion of at least one Mallow extract chosen from Althea officinalis and Malva sylvestris, having from about 2 to about 3% by weight, and preferably about 2.5% by weight, of Mallow extract, wherein aqueous infusions (d) and (e) have a total water content of from about 50 to about 70% by weight, and preferably about 60% by weight, all weights being based on the total weight of the composition; and an emulsifying-effective amount of a dermatologically acceptable emulsifier, wherein the composition is natural and free of a skin sensitizing-effective amount of a volatile essential oil.
- In another embodiment of the present disclosure, the inventors have surprisingly discovered that a natural preservative system comprised of a combination of specific amounts of: a Lactobacillus ferment, a Lactobacillus and Cocos nucifera (coconut) fruit extract, salicylic acid (in some embodiments optional), a salt of a weak acid such as potassium sorbate, and a petroleum-free propanediol, when incorporated into a composition having a specific pH range, effectively both prohibits and inhibits microbial growth on and in the composition.
- The Lactobacillus ferment of the present disclosure is preferably employed in an amount of from about 1 to about 5% by weight, preferably from about 2 to about 4% and more preferably from about 2 to about 4%, by weight of the total composition. An exemplary Lactobacillus ferment is commercially available from Active Micro Technologies under the tradename Leucidal® SF.
- The Lactobacillus and Cocos nucifera fruit extract can include any Cocos nucifera fruit extract fermented with Lactobacillus and/or included with Lactobacillus ferment of the present disclosure and is preferably employed in an amount of from about 1 to about 5%, preferably from about 2 to about 4%, by weight of the total composition. An exemplary Lactobacillus and Cocos nucifera extract is commercially available from Active Micro Technologies under the tradename Amticide® Coconut and is typically associated with the International Nomenclature of Cosmetic Ingredients (INCI) name of a Lactobacillus and Cocos nucifera (coconut) fruit extract.
- When present, salicylic acid is preferably employed in an amount of up to about 0.5% by weight, preferably from about 0.1 to about 0.45% and more preferably from about 0.2 to about 0.4%, by weight of the total composition. It should be noted that the use of salicylic acid in an amount at or greater than about 0.5% by weight, based on the total weight of the composition, renders the composition a drug requiring FDA approval in the prior to commercialization and sale in the United States. In some embodiments, salicylic acid may be omitted by adjusting the concentrations of Lactobacillus ferment, Lactobacillus and Cocos nucifera fruit extract, and/or other ingredients as described in greater detail herein.
- The salt of a weak acid is preferably employed in an amount of up to about 0.5% by weight, preferably from about 0.1 to about 0.45% and more preferably from about 0.2% to about 0.4%, by weight of the total composition. A preferred salt of a weak acid is potassium sorbate (i.e., the potassium salt of sorbic acid). Other weak acids that may be used in their salt form include, but are not limited to, acetic acid, propionic acid, and benzoic acid.
- Petroleum-free 1,3-propanediol is typically employed in an amount of about 1% to about 10% by weight, preferably from about 2% to about 8% and more preferably from about 4% to about 6%, by weight of the total composition. An exemplary petroleum-free 1,3-propanediol is commercially available from Dupont Tate & Lyle Bio Products under the tradename Zemea® Propanediol and can be associated with the INCI name propanediol.
- The inventors have unexpectedly discovered that the ability of the preservative system of the present disclosure to effectively inhibit microorganism growth is critically dependent on the pH of the composition in which it is used. For example, if the preservative system is employed in a composition having a pH of 6, it fails to provide the requisite broad-spectrum protection needed for acceptable storage stability/shelf-life. Accordingly, the pH of a composition containing the preservative system of the present disclosure must be in a range of from about 4.5 to about 5.5, and preferably from about 4.8 to about 5.3.
- According to this embodiment of the present disclosure, there is provided a skincare composition intended for application onto human skin in order to enhance its health and appearance, the composition containing: (1) a preservative system that includes: (a) from about 1 to about 5%, preferably from about 2 to about 4%, by weight of a Lactobacillus ferment; (b) from about 1 to about 5%, preferably from about 2 to about 4%, by weight of a Lactobacillus and Cocos nucifera fruit extract; (c) up to about 0.5%, preferably from about 0.1 to about 0.45% and more preferably from about 0.2 to about 0.4%, by weight of salicylic acid; (d) from about 0.1 to about 0.5% by weight, and preferably from about 0.2 to about 0.4% by weight of at least one salt of a weak acid, preferably potassium sorbate; and (e) from about 1 to about 10%, preferably from about 2 to about 8% and more preferably from about 4 to about 6%, by weight of a petroleum-free propanediol, preferably 1,3-propanediol; (2) a moisturizing/hydrating-effective amount of a mixture of at least: (f) an oil infusion of Calendula officinalis having from about 0.3 to about 0.6% by weight, and preferably about 0.5% by weight, of Calendula officinalis extract, and from about 1 to about 3% by weight, and preferably about 2% by weight of a vegetable oil, preferably almond oil; (g) an oil infusion of Helichrysum italicum having from about 0.9 to about 1.3% by weight, and preferably about 1.2% by weight, of Helichrysum italicum extract, and from about 4 to about 7% by weight, and preferably about 4.7% by weight of a vegetable oil, preferably almond oil; (h) an oil infusion of Symphytum officinale having from about 0.3 to about 0.6% by weight, and preferably about 0.5% by weight, of Symphytum officinale extract, and from about 1 to about 3% by weight, and preferably about 2% by weight of a vegetable oil, preferably almond oil; (i) an aqueous infusion of Viola tricolor having from about 2 to about 3% by weight, and preferably about 2.5% by weight, of Viola tricolor extract; and (j) an aqueous infusion of at least one Mallow extract chosen from Althea officinalis and Malva sylvestris having from about 2 to about 3% by weight, and preferably about 2.5% by weight, of Mallow extract, wherein aqueous infusions (i) and (j) have a total water content of from about 50 to about 70% by weight, and preferably about 60% by weight, all weights being based on the total weight of the composition; and (3) an emulsifying-effective amount of a dermatologically acceptable emulsifier, wherein the composition is natural, free of a skin sensitizing-effective amount of a volatile essential oil, and has a pH ranging from about 4.5 to about 5.5, preferably from about 4.8 to about 5.3.
- In another embodiment of the present disclosure, there is provided a skincare composition intended for application onto human skin in order to enhance its health and appearance, the composition containing: (1) a preservative system that includes: (a) from about 1 to about 5%, preferably from about 2 to about 4% by weight, of a Lactobacillus ferment; (b) from about 1 to about 5%, preferably from about 2 to about 4%, by weight of a Lactobacillus and Cocos nucifera fruit extract; (c) from about 0.1 to about 0.45% by weight, preferably from about 0.2 to about 0.4% of salicylic acid; (d) up to about 0.5% by weight, preferably from about 0.2 to about 0.4% by weight, of at least one salt of a weak acid, preferably potassium sorbate; and (e) from about 1 to about 10%, preferably from about 2 to about 8% by weight, and most preferably from about 4 to about 6% by weight, of a petroleum-free propanediol; (2) a moisturizing/hydrating-effective amount of a mixture of at least: (f) an oil infusion of Calendula officinalis having from about 0.3 to about 0.6% by weight, and preferably about 0.5% by weight, of Calendula officinalis extract, and from about 1 to about 3% by weight, and preferably about 2% by weight of a vegetable oil, preferably almond oil; (g) an oil infusion of Helichrysum italicum having from about 0.9 to about 1.3% by weight, and preferably about 1.2% by weight, of Helichrysum italicum extract, and from about 4 to about 7% by weight, and preferably about 4.7% by weight of a vegetable oil, preferably almond oil; (h) an oil infusion of Symphytum officinale having from about 0.3 to about 0.6% by weight, and preferably about 0.5% by weight, of Symphytum officinale extract, and from about 1 to about 3% by weight, and preferably about 2% by weight of a vegetable oil, preferably almond oil; (i) an aqueous infusion of Viola tricolor having from about 2 to about 3% by weight, and preferably about 2.5% by weight, of Viola tricolor extract; and (j) an aqueous infusion of at least one Mallow extract chosen from Althea officinalis and Malva sylvestris having from about 2 to about 3% by weight, and preferably about 2.5% by weight, of Mallow extract, wherein aqueous infusions (i) and (j) have a total water content of from about 50 to about 70% by weight, and preferably about 60% by weight, all weights being based on the total weight of the composition; and (3) an emulsifying-effective amount of a dermatologically acceptable emulsifier, wherein the composition is natural, free of a skin sensitizing-effective amount of a volatile essential oil, and has a pH ranging from about 4.5 to about 5.5, and preferably from about 4.8 to about 5.3.
- According to yet another embodiment of the present disclosure, there is provided a skincare composition intended for application onto human skin in order to enhance its health and appearance, the composition containing: (1) a preservative system that includes: (a) from about 1 to about 5%, preferably from about 2 to about 4% by weight, of a Lactobacillus ferment; (b) from about 1 to about 5%, preferably from about 2 to about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) from about 0.1 to about 0.45%, preferably from about 0.2 to about 0.4% by weight, of salicylic acid; (d) from about 0.1 to about 0.5% by weight, preferably from about 0.2 to about 0.4% by weight, of at least one salt of a weak acid, preferably potassium sorbate; and (e) from about 1 to about 10%, preferably from about 2 to about 8%, and most preferably from about 4 to about 6% by weight, of a petroleum-free propanediol; (2) a moisturizing/hydrating-effective amount of a mixture of at least: (f) an oil infusion of Calendula officinalis having from about 0.3 to about 0.6% by weight, and preferably about 0.5% by weight, of Calendula officinalis extract, and from about 1 to about 3% by weight, and preferably about 2% by weight of a vegetable oil, preferably almond oil; (g) an oil infusion of Helichrysum italicum having from about 0.9 to about 1.3% by weight, and preferably about 1.2% by weight, of Helichrysum italicum extract, and from about 4 to about 7% by weight, and preferably about 4.7% by weight of a vegetable oil, preferably almond oil; (h) an oil infusion of Symphytum officinale having from about 0.3 to about 0.6% by weight, and preferably about 0.5% by weight, of Symphytum officinale extract, and from about 1 to about 3% by weight, and preferably about 2% by weight of a vegetable oil, preferably almond oil; (i) an aqueous infusion of Viola tricolor having from about 2 to about 3% by weight, and preferably about 2.5% by weight, of Viola tricolor extract; and (j) an aqueous infusion of at least one Mallow extract chosen from Althea officinalis and Malva sylvestris having from about 2 to about 3% by weight, and preferably about 2.5% by weight, of Mallow extract, wherein aqueous infusions (i) and (j) have a total water content of from about 50 to about 70% by weight, and preferably about 60% by weight, all weights being based on the total weight of the composition; and (3) an emulsifying-effective amount of a dermatologically acceptable emulsifier, wherein the composition is natural, free of a skin sensitizing-effective amount of a volatile essential oil, and has a pH ranging from about 4.5 to about 5.5, and preferably from about 4.8 to about 5.3.
- In yet another embodiment of the present disclosure, there is provided a skincare composition intended for application onto human skin in order to enhance its health and appearance, the composition containing: (1) a preservative system comprised of: (a) from about 2 to about 4% by weight, of a Lactobacillus ferment; (b) from about 2 to about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) from about 0.2 to about 0.4% by weight, of salicylic acid; (d) from about 0.2 to about 0.4% by weight, of at least one salt of a weak acid, preferably potassium sorbate; and (e) from about 4 to about 6% by weight, of a petroleum-free propanediol; (2) a moisturizing/hydrating-effective amount of a mixture of at least: (f) an oil infusion of Calendula officinalis having from about 0.3 to about 0.6% by weight, and preferably about 0.5% by weight, of Calendula officinalis extract, and from about 1 to about 3% by weight, and preferably about 2% by weight of a vegetable oil, preferably almond oil; (g) an oil infusion of Helichrysum italicum having from about 0.9 to about 1.3% by weight, and preferably about 1.2% by weight, of Helichrysum italicum extract, and from about 4 to about 7% by weight, and preferably about 4.7% by weight of a vegetable oil, preferably almond oil; (h) an oil infusion of Symphytum officinale having from about 0.3 to about 0.6% by weight, and preferably about 0.5% by weight, of Symphytum officinale extract, and from about 1 to about 3% by weight, and preferably about 2% by weight of a vegetable oil, preferably almond oil; (i) an aqueous infusion of Viola tricolor having from about 2 to about 3% by weight, and preferably about 2.5% by weight, of Viola tricolor extract; and (j) an aqueous infusion of at least one Mallow extract chosen from Althea officinalis and Malva sylvestris having from about 2 to about 3% by weight, and preferably about 2.5% by weight, of Mallow extract, wherein aqueous infusions (i) and (j) have a total water content of from about 50 to about 70% by weight, and preferably about 60% by weight, all weights being based on the total weight of the composition; and (3) an emulsifying-effective amount of a dermatologically acceptable emulsifier, wherein the composition is natural, free of a skin sensitizing-effective amount of a volatile essential oil, and has a pH ranging from about 4.5 to about 5.5, and preferably from about 4.8 to about 5.3.
- According to another embodiment of the present disclosure, there is provided a skincare composition intended for application onto human skin in order to enhance its health and appearance, the composition containing: (1) a preservative system comprised of: (a) from about 2 to about 4% by weight, of a Lactobacillus ferment; (b) from about 2 to about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) from about 0.2 to about 0.4% by weight, of salicylic acid; (d) from about 0.2 to about 0.4% by weight, of at least one salt of a weak acid, preferably potassium sorbate; and (e) from about 4 to about 6% by weight, of a petroleum-free propanediol; (2) a moisturizing/hydrating-effective amount of a mixture of at least: (f) an oil infusion of Calendula officinalis having about 0.5% by weight of Calendula officinalis extract, and about 2% by weight of almond oil; (g) an oil infusion of Helichrysum italicum having about 1.2% by weight, of Helichrysum italicum extract, and about 4.7% by weight of almond oil; (h) an oil infusion of Symphytum officinale having about 0.5% by weight, of Symphytum officinale extract, and about 2% by weight of almond oil; (i) an aqueous infusion of Viola tricolor having about 2.5% by weight, of Viola tricolor extract; and (j) an aqueous infusion of at least one Mallow extract chosen from Althea officinalis and Malva sylvestris having about 2.5% by weight, of Mallow extract, wherein aqueous infusions (i) and (j) have a total water content of about 60% by weight; and (3) about 8.5% by weight of a dermatologically acceptable emulsifier, all weights being based on the total weight of the composition, wherein the composition is natural, free of a skin sensitizing-effective amount of a volatile essential oil, and has a pH ranging from about 4.5 to about 5.5, and preferably from about 4.8 to about 5.3.
- According to another embodiment of the present disclosure, there is provided a skincare composition intended for application onto human skin in order to enhance its health and appearance, the composition containing: (1) a preservative system comprised of: (a) about 4% by weight, of a Lactobacillus ferment; (b) about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) about 0.4% by weight, of potassium sorbate; and (e) about 4% by weight, of a petroleum-free propanediol; (2) a moisturizing/hydrating-effective amount of a mixture of at least: (f) an oil infusion of Calendula officinalis having about 0.5% by weight of Calendula officinalis extract, and about 2% by weight of almond oil; (g) an oil infusion of Helichrysum italicum having about 1.2% by weight, of Helichrysum italicum extract, and about 4.7% by weight of almond oil; (h) an oil infusion of Symphytum officinale having about 0.5% by weight, of Symphytum officinale extract, and about 2% by weight of almond oil; (i) an aqueous infusion of Viola tricolor having about 2.5% by weight, of Viola tricolor extract; and (j) an aqueous infusion of at least one Mallow extract chosen from Althea officinalis and Malva sylvestris having about 2.5% by weight, of Mallow extract, wherein aqueous infusions (i) and (j) have a total water content of about 60% by weight; and (3) about 8.5% by weight of a dermatologically acceptable emulsifier, all weights being based on the total weight of the composition, wherein the composition is natural, free of a skin sensitizing-effective amount of a volatile essential oil, and has a pH ranging from about 4.5 to about 5.5, preferably from about 4.8 to about 5.3.
- According to further embodiments of the disclosure, a skincare composition may comprise (1) a preservative system comprised of: (a) about 4% by weight, of a Lactobacillus ferment; (b) about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) about 0.4% by weight, of potassium sorbate; and (e) about 4% by weight, of a petroleum-free propanediol; (2) an Elderflower hydrosol, infusions of Milk Thistle oil, Castor oil, Safflower oil, and Grapefruit essential oil, and jojoba beads; (3) about 8.5% by weight of a dermatologically acceptable emulsifier; and (4) a dermatologically acceptable carrier, all weights being based on the total weight of the composition, wherein the composition is natural, free of a skin sensitizing-effective amount of an essential oil, free of petroleum-derived ingredients, and has a pH ranging from about 4.5 to about 5.5, preferably from about 4.8 to about 5.3.
- Elderflower hydrosol provides plant acids that gently tone the skin. Milk Thistle oil comprises antioxidant properties to protect the skin, e.g. from UV radiation. Castor and Safflower oil reduce pore size, increase hydration, and offer superior cleansing abilities. Grapefruit essential oil provides an uplifting scent with toning properties. Jojoba beads provide light exfoliation without causing skin irritation.
- In another embodiment of the disclosure, a composition intended for application onto human skin in order to enhance its health and appearance is provided, the composition comprising: (1) a preservative system comprised of: (a) about 4% by weight, of a Lactobacillus ferment; (b) about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) about 0.4% by weight, of potassium sorbate; and (e) about 4% by weight, of a petroleum-free propanediol; (2) Helichrysum italicum, cucumber, aloe vera, and infusions of Arnica oil and Bladder Wrack oil; (3) about 8.5% by weight of a dermatologically acceptable emulsifier; and (4) a dermatologically acceptable carrier, all weights being based on the total weight of the composition, wherein the composition is natural, free of a skin sensitizing-effective amount of an essential oil, free of petroleum-derived ingredients, and has a pH ranging from about 4.5 to about 5.5, preferably from about 4.8 to about 5.3.
- Arnica oil reduces puffiness around the eyes. Bladder Wrack oil helps reduce moisture loss and protects the skin against irritation. Helichrysum italicum advantageously provides a moisture-retentive film to keep the skin hydrated, while cucumber provides amino acids, proteins, and lipids that help to pump and calm the skin. Aloe vera soothes and hydrates the skin while increasing firmness.
- In another embodiment of the disclosure, a composition intended for application onto human skin in order to enhance its health and appearance is provided, the composition comprising: (1) a preservative system comprised of: (a) about 4% by weight, of a Lactobacillus ferment; (b) about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) about 0.4% by weight, of potassium sorbate; and (e) about 4% by weight, of a petroleum-free propanediol; (2) Calendula-infused oil and water, Serrated Wrack, Hyaluronic acid from about 1 to about 3% by weight, Sweet Almond oil, and Green Mandarin oil; (3) about 8.5% by weight of a dermatologically acceptable emulsifier; and (4) a dermatologically acceptable carrier, all weights being based on the total weight of the composition, wherein the composition is natural, free of a skin sensitizing-effective amount of an essential oil, free of petroleum-derived ingredients, and has a pH ranging from about 4.5 to about 5.5, preferably from about 4.8 to about 5.3.
- Calendula-infused oil and water improve skin distensibility, firmness, and viscoelasticity. Serrated Wrack improves skin suppleness by moisturizing and improving the skin barrier. Hyaluronic acid, in a range from, for example, about 1% by weight to about 3% by weight, boosts the skin's ability to absorb moisture and results in smoother, softer skin. Sweet Almond oil softens the skin. Green Mandarin oil tones and helps balance oil production in the skin.
- In another embodiment of the disclosure, a composition intended for application onto human skin in order to enhance its health and appearance is provided, the composition comprising: (1) a preservative system comprised of: (a) about 4% by weight, of a Lactobacillus ferment; (b) about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) about 0.4% by weight, of potassium sorbate; and (e) about 4% by weight, of a petroleum-free propanediol; (2) Rosehip oil, Bog Myrtle, Sea Buckthorn, Prickly Pear Seed oil, Serrated Wrack, Rosemary, Kiwi Seed oil, and Baobab oil; (3) about 8.5% by weight of a dermatologically acceptable emulsifier; and (4) a dermatologically acceptable carrier, all weights being based on the total weight of the composition, wherein the composition is natural, free of a skin sensitizing-effective amount of an essential oil, free of petroleum-derived ingredients, and has a pH ranging from about 4.5 to about 5.5, preferably from about 4.8 to about 5.3.
- Rosehip oil soothes, moisturizes, and softens the skin, and further contains Vitamins A and C. It is also rich in essential fatty acids. Bog Myrtle helps keep pores clean and provides antioxidants. Sea Buckthorn helps retain moisture and improve skin elasticity, and further contains vitamins, minerals, and omega-3 fatty acids. Prickly Pear Seed oil reduces hyperpigmentation, and further contains vitamins E and K and is rich in essential fatty acids. Serrated Wrack helps improve the suppleness and elasticity of the skin, and contains minerals and trace elements. Rosemary protects the skin from environmental stressors. Kiwi Seed oil controls sebum production and helps maintain clear skin. Baobab oil gives elasticity to the skin and contains vitamins A, D, E, and F.
- The skincare compositions of the present disclosure may be in a wide variety of product forms that include, but are not limited to, solutions, suspensions, lotions, creams, gels, sprays, ointments and serums. For example, a product intended for application onto skin, post-shaving, in order to help relieve the irritation associated with the mechanical stress on the skin caused by the shaving process, can be formulated using the above-described compositions as a base formula.
- According to embodiments of the present disclosure, the skincare compositions can comprise other suitable, optional ingredients as desired. For example, the composition can optionally include other active or inactive ingredients, provided they do not unacceptably alter the benefits of the skincare composition, are natural, and do not promote skin sensitization. The precise amount of optional ingredients will be determined by those skilled in the art. Examples of other ingredients that may be employed include, but are not limited to, humectants, emollients, flavonoids, minerals, chelating agents, pH regulators/buffers, rheology modifiers, phytosterols, vitamin B3 compound, anti-inflammatory agents such as licorice extracts, bisabolol, manjistha extracted from plants in the genus Rubia, guggal extracted from plants in the genus Commiphora, Quillaja saponaria extract, kola extract, chamomile, red clover extract, sea whip extract, hibiscus extract, lucuma extract, sea kale extract, Iceland Moss extract, Saskatoon Berry extract, Siberian Ginseng extract, spruce needles extract, birch bark extract, blueberry extract, cranberry extract, yarrow extract, marigold extract and couch grass extract.
- Additional ingredients that may be employed in order to further potentiate the efficacy of embodiments of the disclosure may include, for example, Astrocaryum murumuru seed butter, Theobroma grandiflorum seed butter, Spondias mombin pulp extract, Mangifera indica pulp extract, Musa sapientum pulp extract, Mauritia flexuosa fruit oil, Physalis angulata extract, Xylityl sesquicaprylate, Vaccinium myrtillus seed oil, Cucubita pepo seed extract, linoleic acid, Centella asiatica leaf extract, Tamarindus indica seed polysaccharide, Zanthoxylum bungeanum fruit extract, Lactococcus ferment lysate, Bellis perennis flower extract, Coffea arabica seed cake extract, Coffea arabica seed oil, cotton seed oil, linseed oil, Pichia ferment lysate filtrate, and whey protein.
- The dermatologically acceptable carrier can encompass a wide variety of forms. In some cases, the solubility or dispersibility of the components in the composition may dictate the form and character of the carrier. Non-limiting examples include simple solutions (e.g., aqueous or anhydrous), dispersions, emulsions and solid forms. In certain embodiments, the dermatologically acceptable carrier is in the form of an emulsion. An emulsion can be generally classified as having a continuous aqueous phase (e.g., oil-in-water and water-in-oil-in-water) or a continuous oil phase (e.g., water-in-oil or oil-in-water). While the oil phase may comprise any vegetable oil, so long as it does not cause skin sensitization, a particularly preferred oil component is almond oil. The inventors have surprisingly discovered that the use of almond oil enables bioactive compounds present in the botanical extract to effectively penetrate into the skin, without the need of having to use skin-sensitizing essential oils, while still facilitating the desired degree of efficacy. This is due to almond oil being rich in beta-zoosterol, squalene, and alpha-tocopherol, together will lesser amounts of carbohydrates, proteins, vitamins and minerals such as vitamin B complex and zinc. Moreover, almond oil's phytochemicals are believed to be effective at promoting surface level proliferation and skin cell development. Other vegetable oils that may also be used include, but are not limited to, olive oil, jojoba oil, babassu oil, caster oil, coconut oil, corn oil, cotton seed oil, linseed oil, mustard oil, safflower oil, sesame oil, soybean oil, sunflower-seed oil, wheat germ oil, argan oil and manila oil.
- As has been noted above, individuals at times suffer from compromised skin that can be caused by extrinsic and/or intrinsic influences. In those instances, the use of a topical product capable of moisturizing, hydrating and soothing the skin in order to alleviate symptoms associated with this condition is highly desirable. Although there are a number of products commercially available for addressing this condition, they oftentimes contain synthetic ingredients. One example of just such a product is EUCERIN® commercially available from Beiersdorf of Hamburg, Germany. For those individuals wanting to avoid applying any synthetic, potentially skin-sensitizing ingredients onto already compromised skin, topical products that are natural, organic, ECOCERT®-approved, yet efficacious are needed.
- Thus, according to yet another embodiment, the present disclosure is also directed to a method of treating compromised skin by applying one of the above-disclosed compositions onto the compromised skin.
- The following examples as set forth herein are intended for illustrative purposes only and are not intended to limit the scope of the disclosure in any way, as many variations thereof are possible without departing from the spirit and scope of the disclosure. In the examples, all concentrations are listed as weight percent, unless otherwise specified.
-
-
% % % almond Ingredients wt/wt extract oil Helichrysum italicum 5.9 1.2 4.7 Calendula officinalis 2.5 0.5 2.0 Symphytum officinale 2.5 0.5 2.0 emulsifiers 8.5 Lactobacillus ferment 4.0 Lactobacillus and Cocos nucifera 4.0 fruit extract Potassium sorbate 0.4 1,3-propanediol 4.0 Viola tricolor 2.5 Althea officinalis 2.5 Purified water 60.9 Additives q.s. Total 100 - The composition of Example 1 was clinically tested in order to determine its efficacy in enhancing skin health and appearance. Thirty-six individuals aged 45-65 were asked to apply the composition twice a day at home, once in the morning and once in the evening, under normal use conditions, as a replacement for their normal skin treatment routine. Skin health and appearance data were collected on day zero, day 28, day 56, and day 84.
- The skin-smoothing and anti-wrinkle effect of the composition was determined in-vivo using the fringe projection system DermaTOP® and its attendant acquisition software. This system measures the height of projections in μm emanating from the skin used to assess skin roughness and severity of wrinkles on the skin. A decrease in projection height evidences smoother, less wrinkled skin. The data clearly evidence the skin-smoothing/anti-wrinkling effect of the composition, as shown in Table 1 below.
-
TABLE 1 Δ% on % of subjects with Parameters and Kinetics mean the expected effect Average Roughness (μm) D 28 −1% 56% Average Roughness (μm) D 56 +1% 45% Average Roughness (μm) D 84 −5% 72% Average Relief (μm) D 28 −2% 56% Average Relief (μm) D 56 +1% 42% Average Relief (μm) D 84 −5% 69% Maximum relief amplitude (μm) D 28 −2% 50% Maximum relief amplitude (μm) D 56 +2% 42% Maximum relief amplitude (μm) D 84 −6% 72% - As demonstrated by the data shown in Table 1 above, there was a 5% decrease in the average roughness of 72% of test subjects' skin on day 84. A 5% decrease in the average height of skin wrinkles was observed in 69% of test subjects' skin on day 84. A 6% decrease in the maximum height of skin wrinkles was observed in 72% of test subjects' skin on day 84. The data demonstrate a significant smoothing and anti-wrinkle effect for a vast majority of users at the end of the test period by using the natural skincare composition according to Example 1.
- The skin-firming effect of the composition was determined using an add-on to the DermaTOP® system known as DynaSKIN® and its attendant dedicated software. This system measures the skin-deformation parameters of volume, surface and depth associated with firmness and laxity of the skin and its sag. A decrease in the volume, surface and depth of skin deformation corresponds to an increase in skin firmness. The data pertaining to volume, surface, and maximum depth improvements after use of the composition according to Example 1 are presented in Table 2.
-
TABLE 2 Δ% on % of subjects with Parameters and Kinetics mean the expected effect Volume (mm3) D 28 −8% 72% Volume (mm3) D 56 −12% 56% Volume (mm3) D 84 −21% 82% Surface (mm2) D 28 −3% 58% Surface (mm2) D 56 −4% 76% Surface (mm2) D 84 −7% 71% Maximum depth (mm) D 28 −5% 69% Maximum depth (mm) D 56 −7% 59% Maximum depth (mm) D 84 −16% 71% - As demonstrated by the data in Table 2, use of the natural skincare composition according to Example 1 resulted in less voluminous and less extended deformation of test subjects' skin. The improvements to test subjects' skin firmness, laxity, and sag increased with time, with the vast majority experiencing significant reductions in skin deformation. For instance, over 70% of test subjects experienced a 21% decrease in volume, 7% decrease in surface, and 16% decrease in depth of deformation after 84 days of using the natural skincare composition.
- Moisturization/hydration data was obtained using a Corneometer®, which measures capacitance of the skin, which corresponds to the humidity level of the measured skin. An increase in Corneometer® value corresponds therefore to a desired increase in moisturization/hydration. The data pertaining to skin-moisturization are presented below in Table 3.
-
TABLE 3 Δ% on % of subjects with Parameters and Kinetics mean the expected effect Cutaneous hydration rate D 28 19% 89% Cutaneous hydration rate D 56 36% 94% Cutaneous hydration rate D 84 52% 100% - The data presented in Table 3 demonstrate the skin-moisturizing benefits of the natural skincare composition according to Example 1. Test subjects experienced a 19% increase in skin moisture after 28 days, a 36% increase after 56 days, and a 52% increase after 84 days, with 100% of test subjects experiencing the increase at 84 days.
- The anti-aging effect of the composition was determined using a high-frequency echograph Dermascan® C 2D instrument which measures combined dermis and epidermis thickness. The device emits an ultrasound beam that generates a two-dimensional image of the dermis and epidermis used to measure the thickness of the skin. As a person ages, their skin naturally becomes thinner. Thus an increase in thickness between the epidermis and the dermo-hypodermis junction (which abuts the dermis) corresponds to a positive anti-aging effect. The data corresponding to the measurement are presented below in Table 4.
-
TABLE 4 Δ% on % of subjects with Parameters and Kinetics mean the expected effect Thickness of epidermis-dermis (mm) D 28 3% 64% Thickness of epidermis-dermis (mm) D 56 6% 85% Thickness of epidermis-dermis (mm) D 84 6% 85% - As seen in Table 4 above, the natural skincare composition according to Example 1 has substantial anti-aging effects including a thicker epidermis-dermis after 28, 56, and 84 days of use, with 85% of test subjects showing a 6% increase in thickness after 84 days.
- Another tool/data point used to determine skin health is SquameScan® software in conjunction with D-Squame® tape strips. This tool is designed to measure IR-light absorption and thereby determine stratum-corneum protein content on the D-Squame® strip. A decrease in light absorption corresponds to a decrease in the amount of protein detected, thus evidencing that the skin has experienced a desirable skin restructuring effect. The data from this measurement are provided below in Table 5.
-
TABLE 5 Δ% on % of subjects with Parameters and Kinetics mean the expected effect Light absorption (%) D 28 −5% 47% Light absorption (%) D 56 −13% 59% Light absorption (%) D 84 −19% 76% - As illustrated by the data in Table 5 above, statistically significant improvements to skin restructuring are observed in a majority of test subjects after 56 and 84 days, with a 13% and 19% decrease in UV absorption, respectively. The data demonstrate that the natural skincare composition according to Example 1 aids in skin restructuring effects.
- The above-discussed in-vivo clinical testing clearly and quantitatively establishes, the significant impact on skin health and appearance achieved by the use the inventive composition of Example 1, with benefits such as smoother, less-wrinkled, firmer, more-moisturized, thicker, and restructured skin.
- The test subjects were then asked to assess, qualitatively, their impression of the composition of Example 1 with respect to its sensorial qualities in general and its efficacy after 56 and 84 days of use. The test subjects all appreciated the sensorial qualities of the product with regards to its texture, color, ease of application, and non-greasy/non-sticky feel on their skin. With regards to their perception of the product's efficacy, they all believed that after 56, and especially 84 days of use their skin was more moisturized, nourished, comfortable, smooth, elastic, firm, dense, brightened/luminous, re-tightened, detoxified, healthy and more uniform in appearance.
- The efficacy of a skincare composition according to embodiments of the present disclosure and incorporated into different cosmetic products was measured against a leading cosmetic product. Five cosmetic products incorporating the skincare composition, including a face, hands, and body cream, an exfoliating wash, an eye gel cream, a day cream, and a facial oil, were measured against the leading cosmetic product, a day cream, using quantifiable metrics as described herein. Each of the users who participated in the study were instructed to wash their face for a one-week period using Cetaphil® Gentle Skin Cleanser prior to the study and to refrain from using any anti-aging treatments/products during the washout period and for the duration of the study.
- The five cosmetic products incorporating the skincare composition according to embodiments of the disclosure and the leading cosmetic product were assessed using one or more quantifiable metrics such as a Corneometer® measurement, a Tewameter® measurement, Image Pro® software, a D-Squame® measurement, a Sebumeter® measurement, and a Cutometer® measurement.
- As with Example 1, moisturization/hydration data was obtained using a Corneometer®, which measures capacitance of the skin, which corresponds to the humidity level of the measured skin. Since water is known to be an excellent conductor of electricity, an increase in electrical conductance corresponds to an increase in skin's hydration/moisture levels. An increase in Corneometer® value corresponds therefore to a desired increase in moisturization/hydration.
- SquameScan® software was used in conjunction with D-Squame® tape strips to measure IR-light absorption and thereby determine stratum-corneum protein content on the D-Squame® strip. This measures the ability of the skin's outermost layer to effectively protect the body from external factors light sunlight and pollution, as well as retain moisture to prevent it from becoming dry, and is determined by the amount of particular skin proteins found in this layer. Specially designed tape is first applied onto the skin to remove dead skin cells from the surface, at which point the amount of protein in the cells is measured. A decrease in light absorption corresponds to a decrease in the amount of protein detected, thus evidencing that the skin has experienced a desirable skin restructuring effect.
- Transepidermal water loss (TEWL) was evaluated using a Tewameter®, such as is available from Courage+Khazaka electronic GmbH of Köln, Germany, or alternatively by a VapoMeter from Delfin Technologies of Kuopio, Finland. This device measures skin's ability to retain water. When water passes through the skin, which is a natural biological process, and evaporates from the skin's surface, this phenomenon is referred to as TEWL and is a measure of skin's ability to retain moisture present in the dermis. If the skin's ability to retain moisture is enhanced after use of a product, its effectiveness as a moisturizer is confirmed.
- Skin structure and dryness are measured using high-resolution images of the skin captured with a Visioscan®, also of Courage+Khazaka electronic GmbH.
- Oil content on the skin was measured using a Sebumeter®, also of Courage+Khazaka electronic GmbH. The Sebumeter® evaluates the effectiveness of a product intended to reduce oil content on the skin by grease-spot photometry, in which the tape of the device contacts a user's skin and is then measured by a photocell.
- Skin elasticity was measured using a Cutometer® available also from Courage+Khazaka electronic GmbH. The Cutometer® uses a suction method in which negative pressure mechanically deforms the skin. Skin is withdrawn into an aperture of a probe for a defined time, and measured using a non-contact optical measuring system. The resistance of the skin to the negative pressure represents firmness and its ability to return to its original position represents elasticity. Accordingly, a decrease in Cutometer® measurements indicates an improvement in skin firmness.
- The face, hands, and body cream used in the study comprises (1) a preservative system comprising: (a) from about 2 to about 4% by weight, of a Lactobacillus ferment; (b) from about 2 to about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) from about 0.2 to about 0.4% by weight, of salicylic acid; (d) from about 0.2 to about 0.4% by weight, of at least one salt of a weak acid, preferably potassium sorbate; and (e) from about 4 to about 6% by weight, of a petroleum-free propanediol; (2) a moisturizing/hydrating-effective amount of a mixture of at least: (f) an oil infusion of Calendula officinalis having about 0.5% by weight of Calendula officinalis extract, and about 2% by weight of almond oil; (g) an oil infusion of Helichrysum italicum having about 1.2% by weight, of Helichrysum italicum extract, and about 4.7% by weight of almond oil; (h) an oil infusion of Symphytum officinale having about 0.5% by weight, of Symphytum officinale extract, and about 2% by weight of almond oil; (i) an aqueous infusion of Viola tricolor having about 2.5% by weight, of Viola tricolor extract; and (j) an aqueous infusion of at least one Mallow extract chosen from Althea officinalis and Malva sylvestris having about 2.5% by weight, of Mallow extract, wherein aqueous infusions (i) and (j) have a total water content of about 60% by weight; and a dermatologically acceptable emulsifier, and has a pH ranging from about 4.5 to about 5.5, preferably from about 4.8 to about 5.3. The combination of Calendula officinalis, Helichrysum italicum, Symphytum officinale, Viola tricolor, and at least one Mallow extract beneficially provides synergistic effects on the skin, including moisturizing the skin, protecting the skin with a film, shedding dry outer layers of the epidermis, improving osmotic function, and providing a soothing gel, as described above.
- The exfoliating wash used in the study comprises a skincare composition comprises (1) a preservative system comprising (a) from about 2 to about 4% by weight, of a Lactobacillus ferment; (b) from about 2 to about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) from about 0.2 to about 0.4% by weight, of salicylic acid; (d) from about 0.2 to about 0.4% by weight, of at least one salt of a weak acid, preferably potassium sorbate; and (e) from about 4 to about 6% by weight, of a petroleum-free propanediol; (2) at least one of an Elderflower hydrosol; infusions of Milk Thistle oil; Castor oil; Safflower oil; Grapefruit essential oil; and jojoba beads; and (3) a dermatologically acceptable emulsifier, and has a pH ranging from about 4.5 to about 5.5, preferably from about 4.8 to about 5.3. This combination of ingredients advantageously provides synergistic effects that gently tone the skin, provide antioxidants, reduce pore size while cleaning and hydrating, provide uplifting scents, and lightly exfoliate the skin without irritation.
- The eye gel cream used in the study comprises a skincare composition comprises (1) a preservative system comprising (a) from about 2 to about 4% by weight, of a Lactobacillus ferment; (b) from about 2 to about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) from about 0.2 to about 0.4% by weight, of salicylic acid; (d) from about 0.2 to about 0.4% by weight, of at least one salt of a weak acid, preferably potassium sorbate; and (e) from about 4 to about 6% by weight, of a petroleum-free propanediol; (2) at least one of Helichrysum italicum; cucumber; aloe vera; and infusions of Arnica oil and Bladder Wrack oil; and (3) a dermatologically acceptable emulsifier, and has a pH ranging from about 4.5 to about 5.5, preferably from about 4.8 to about 5.3. This combination of ingredients advantageously reduces puffiness around the eyes, reduces irritation and moisture loss, hydrates the skin by providing a moisture-retentive film, provides amino acids, proteins and lipids that plump and calm the skin, and soothes and hydrates the skin while increasing firmness.
- The day cream used in the study comprises a skincare composition comprises (1) a preservative system comprising (a) from about 2 to about 4% by weight, of a Lactobacillus ferment; (b) from about 2 to about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) from about 0.2 to about 0.4% by weight, of salicylic acid; (d) from about 0.2 to about 0.4% by weight, of at least one salt of a weak acid, preferably potassium sorbate; and (e) from about 4 to about 6% by weight, of a petroleum-free propanediol; (2) at least one of Calendula-infused oil and water; Serrated Wrack; Hyaluronic acid from about 1 to about 3% by weight; Sweet Almond oil; and Green Mandarin oil; and (3) a dermatologically acceptable emulsifier, and has a pH ranging from about 4.5 to about 5.5, preferably from about 4.8 to about 5.3. This combination of ingredients advantageously improves skin distensibility, firmness, and viscoelasticity, improves skin suppleness and elasticity by moisturizing and improving the skin barrier, boosts the skin's ability to absorb moisture resulting in smoother, softer skin, and tones and balances oil production of the skin.
- The facial oil used in the study comprises a skincare composition comprises (1) a preservative system comprising (a) from about 2 to about 4% by weight, of a Lactobacillus ferment; (b) from about 2 to about 4% by weight, of a Lactobacillus and Cocos nucifera fruit extract; (c) from about 0.2 to about 0.4% by weight, of salicylic acid; (d) from about 0.2 to about 0.4% by weight, of at least one salt of a weak acid, preferably potassium sorbate; and (e) from about 4 to about 6% by weight, of a petroleum-free propanediol; (2) at least one of Rosehip oil; Bog Myrtle; Sea Buckthorn; Prickly Pear Seed oil; Serrated Wrack; Rosemary; Kiwi Seed oil; and Baobab oil; and (3) a dermatologically acceptable emulsifier, and has a pH ranging from about 4.5 to about 5.5, preferably from about 4.8 to about 5.3. This combination of ingredients advantageously smoothes, moisturizes, and softens the skin, providing vitamins A, C, D, E, and K and essential fatty acids, cleans the pores, provides antioxidants, retains moisture and improves skin elasticity and suppleness, reduces hyperpigmentation, protects the skin from environmental stressors, controls sebum production, and maintains clear skin.
- It will be understood that the above cosmetic products and listed ingredients are merely exemplary and may further comprise any necessary components such as emulsifiers, fragrances, natural preservatives, and other ingredients within any suitable proportion.
- It has been surprisingly found that the five cosmetic products incorporating the skincare compositions described above achieve enhanced skincare relative to the leading dermatological product as well as compared to baseline skin health across numerous quantifiable metrics as described in greater detail below. The leading dermatological product used as a benchmark is a moisturizing cream comprising conventional dermatological ingredients, as well as hyaluronic acid, dimethicone, and ceramides.
- Users' skin was first measured using a Corneometer® as described above to assess skin hydration and compared against a control group using the leading dermatological product. Measurements were taken at the outset of the study to establish a baseline measurement, after 14 days, and after 28 days. The results are shown below in Table 6, in which a positive value represents an improvement in skin hydration.
-
TABLE 6 Day 14 Day 28 % Change from % % Change from % Baseline Subjects Baseline Subjects Leading 77.4 100 90.2 100 Dermatological Product Face, hands, and 22.1 83 42.5 90 body cream Day Cream 52 100 50.1 100 Facial Oil 133.7 100 168.2 100 Eye Gel Cream 86.9 100 70.1 100 - As shown from the results of Table 6 above, the skincare compositions according to the disclosure universally achieve an improvement in skin hydration for all or a large majority of users, with the facial oil comprising the skincare composition achieving an especially marked improvement relative to baseline hydration and relative to the leading dermatological product.
- Users' skin was also measured to assess skin barrier function—as indicated by transepidermal water loss (TEWL)—using a Tewameter® as described above. Measurements were taken at the outset of the study to establish a baseline measurement, after 14 days, and after 28 days. The results are shown below in Table 7, in which a negative value represents an improvement in skin barrier function.
-
TABLE 7 Day 14 Day 28 % Change from % % Change from % Baseline Subjects Baseline Subjects Leading −1.9 59 −5.0 63 Dermatological Product Face, hands, and −7.0 57 −13.4 77 body cream Day Cream 0.9 47 −4.5 50 Facial Oil −6.5 83 −11.2 83 Exfoliating Wash −13.1 81 −14.0 74 - As seen from the results in Table 7, the skincare compositions of the disclosure as embodied in four of the five skincare products achieve universally an improvement in skin barrier function relative to baseline by day 28, and with the exception of the Day Cream product achieve a larger improvement for a larger percentage of users than the leading dermatological product.
- Users' skin was also measured to assess skin texture using image analysis. At each evaluation, digital images of the face of each user were taken from the front, right, and left. The images were analyzed using Image Pro® software of MediaCybernetics of Bethesda, Md., to determine changes to the following parameters: skin texture/smoothness, under eye puffiness, and under eye discoloration.
- Visia CR® was used to generate a texture score for the skin based on the mean intensities of the red, green, and blue pixels of the captured images. A decrease in the texture score calculated according to this method represents an improvement in overall skin texture. Under-eye puffiness is determined in a similar manner.
- Under-eye discoloration was measured by assessing chroma. The degree to which a color is free from being mixed with other colors indicates its chromaticity. An increase in chromaticity represents an improvement in under-eye discoloration.
- Measurements were taken at the outset of the study to establish a baseline measurement, after 14 days, and after 28 days. The results of the skin-texture assessment are shown below in Table 8, in which a negative value represents an improvement in skin texture.
-
TABLE 8 Day 14 Day 28 % Change from % % Change from % Baseline Subjects Baseline Subjects Leading 4.8 19 −1.9 81 Dermatological Product Face, hands, and 1.1 45 −2.2 80 body cream Day Cream 1.5 47 −5.1 77 Facial Oil −1.7 60 −5.2 77 - As seen in Table 8 above, the use of skincare compositions according to the disclosure advantageously improves skin texture relative to the leading dermatological product, and in most cases for a larger number of users.
- Results for under-eye puffiness and discoloration assessed using the Image Pro® method described above are shown in Tables 9 and 10 below, in which a negative value and a positive value, respectively, represent an improvement.
-
TABLE 9 Day 14 Day 28 % Change from % % Change from % Baseline Subjects Baseline Subjects Leading 2.6 38 −2.1 78 Dermatological Product Eye gel cream −0.7 71 −0.6 71 - As seen from the results shown in Table 9 above, the use of skincare compositions according to the present disclosure advantageously improve a user's under-eye puffiness, particularly after 14 days, in which period the improvement is more substantial and observed over a larger percentage of users than for the leading dermatological product.
-
TABLE 10 Day 14 Day 28 % Change from % % Change from % Baseline Subjects Baseline Subjects Leading −0.03 56 0.31 47 Dermatological Product Eye gel cream 0.3 52 1.7 77 - As seen from the results in Table 10 above, the use of skincare compositions according to the present disclosure advantageously improve a user's under-eye discoloration compared to the leading dermatological product and for a larger percentage of users.
- A Sebumeter® was used to measure facial sebum/oil levels of users using the leading dermatological product, the facial oil, and the exfoliating wash. The results are shown in Table 11 below, wherein a negative value represents an improvement.
-
TABLE 11 Day 14 Day 28 % Change from % % Change from % Baseline Subjects Baseline Subjects Leading −15.0 75 −19.2 81 Dermatological Product Facial oil −22.5 90 −27.5 93 Exfoliating wash −5.5 55 4.2 39 - As seen from the results in Table 11 above, the skincare compositions according to the disclosure advantageously improve a user's facial sebum/oil levels compared to baseline and to a greater degree and for a greater percentage of users than the leading dermatological product, particularly when used in the facial oil product.
- Users' skin flakiness was compared using D-Squame® as described above and assessed across the leading dermatological product, the face, hands, and body cream, the day cream, the facial oil, and the exfoliating wash products. The results of the D-Squame® measurements are shown in Table 12 below, in which a negative value represents an improvement in skin flakiness.
-
TABLE 12 Day 14 Day 28 % Change from % % Change from % Baseline Subjects Baseline Subjects Leading −26.4 84 −41.2 100 Dermatological Product Face, hands, and −21.6 73 −40.5 100 body cream Day Cream −33 93 −50 100 Facial Oil −28.6 100 −42.9 100 Exfoliating Wash −26.5 74 −47.1 100 - As seen from the results in Table 12 above, the skincare compositions of the disclosure advantageously improve universally skin flakiness relative to baseline, and certain of the disclosed embodiments show greater improvement for a higher percentage of users than the leading dermatological product.
- The users' skin firmness was also measured using a Cutometer® and assessed for both the leading dermatological product and the facial oil product, the results of which are shown in Table 13 below. A negative value indicates an improvement to skin firmness.
-
TABLE 13 Day 14 Day 28 % Change from % % Change from % Baseline Subjects Baseline Subjects Leading −29.0 69 −47.3 75 Dermatological Product Facial oil −21.8 73 −24.4 30 - As seen from the results of Table 13 above, the use of skincare compositions according to the disclosure advantageously improves a user's skin firmness relative to baseline.
- By providing a skincare composition and method for using the same according to embodiments of the disclosure, the problem of existing cosmetics such as moisturizers using harmful synthetic and/or petroleum-based ingredients, and the problem of “all-natural” cosmetics lacking credible and/or rigorous demonstrations of their efficacy and benefits, is addressed. The composition comprising a combination of natural botanical ingredients such as Calendula officinalis, Helichrysum italicum, Symphytum officinale, Viola tricolor, and Mallow moisturizes, soothes, and nourishes the skin by providing a protective film and gel on the skin, helping the skin shed the dry outer layers of the epidermis and by improving osmotic function to better retain water while avoiding the undesirable complications of synthetic and/or petroleum-based moisturizers. The compositions may further be combined with an all-natural preservative system that improves the chemical stability and shelf-life of the composition without using harsh, irritating synthetic preservatives.
- The skilled artisan will recognize the interchangeability of various components and ingredients from the embodiments described. Besides the variations described, other known equivalents for each feature can be mixed and matched by one of ordinary skill in this art to prepare a skincare composition under principles of the present disclosure. Therefore, the embodiments described may be adapted to compositions for any purpose and utilizing any suitable ingredient.
- While the foregoing embodiments have been described, it is understood that alternatives and modifications of these embodiments, such as those suggested by others, may be made to fall within the scope of the disclosure.
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/818,749 US20220378690A1 (en) | 2019-05-27 | 2022-08-10 | Compositions and methods for treating skin |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962853116P | 2019-05-27 | 2019-05-27 | |
US201962853588P | 2019-05-28 | 2019-05-28 | |
US201962861745P | 2019-06-14 | 2019-06-14 | |
US16/669,098 US10682306B1 (en) | 2019-05-27 | 2019-10-30 | Compositions and methods for treating skin |
US16/901,795 US20200375887A1 (en) | 2019-05-27 | 2020-06-15 | Compositions and methods for treating skin |
US17/818,749 US20220378690A1 (en) | 2019-05-27 | 2022-08-10 | Compositions and methods for treating skin |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/901,795 Continuation US20200375887A1 (en) | 2019-05-27 | 2020-06-15 | Compositions and methods for treating skin |
Publications (1)
Publication Number | Publication Date |
---|---|
US20220378690A1 true US20220378690A1 (en) | 2022-12-01 |
Family
ID=68771758
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/669,098 Active US10682306B1 (en) | 2019-05-27 | 2019-10-30 | Compositions and methods for treating skin |
US16/901,795 Abandoned US20200375887A1 (en) | 2019-05-27 | 2020-06-15 | Compositions and methods for treating skin |
US17/818,749 Abandoned US20220378690A1 (en) | 2019-05-27 | 2022-08-10 | Compositions and methods for treating skin |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/669,098 Active US10682306B1 (en) | 2019-05-27 | 2019-10-30 | Compositions and methods for treating skin |
US16/901,795 Abandoned US20200375887A1 (en) | 2019-05-27 | 2020-06-15 | Compositions and methods for treating skin |
Country Status (5)
Country | Link |
---|---|
US (3) | US10682306B1 (en) |
EP (1) | EP3976205A1 (en) |
JP (1) | JP2022534485A (en) |
CN (1) | CN113853195B (en) |
WO (1) | WO2020242516A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT202000017188A1 (en) * | 2020-07-15 | 2020-10-15 | O F I Officina Farm Italiana S P A | DERMATOLOGICAL COMPOSITION FOR REBALANCING THE SKIN, TO INCREASE IRMHYDRATION AND ELASTICITY AND TO REDUCE DISCOLORATION |
CZ309926B6 (en) * | 2021-07-01 | 2024-02-07 | Dr Konrad Pharma s.r.o. | Vitamin ointment |
IT202200027399A1 (en) * | 2023-01-02 | 2024-07-02 | Capurso Dairy Company Srl | Advanced method for sustainable production of perfumed creams with high antioxidant power from dairy process whey |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150328087A1 (en) * | 2014-05-16 | 2015-11-19 | Restorsea, Llc | Biphasic cosmetic |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU83173A1 (en) | 1981-02-27 | 1981-06-05 | Oreal | NOVEL COSMETIC COMPOSITIONS FOR THE TREATMENT OF HAIR AND SKIN CONTAINING POWDER RESULTING FROM THE SPRAYING OF AT LEAST ONE PLANT AND A COHESION AGENT |
KR101238730B1 (en) | 2004-07-28 | 2013-03-04 | 카아길, 인코포레이팃드 | Physiologically active composition based on collagen |
WO2006032091A2 (en) | 2004-09-21 | 2006-03-30 | Lavender Hill Projects Pty Ltd | Herbal composition |
CN101384241A (en) * | 2006-02-14 | 2009-03-11 | 株式会社芳珂 | Agent for promoting vitamin C transporter production |
RS20100392A3 (en) | 2010-09-06 | 2012-12-31 | Pavlov, Aleksandar | Procedure for obtaining herbal preparation based on herbal mixture extract for application on skin and herbal preparation obtained thereof |
GB201019297D0 (en) | 2010-11-15 | 2010-12-29 | Pitt Elaine | Improved compositions |
WO2013149323A1 (en) | 2012-04-02 | 2013-10-10 | Ntegrity | Natural products for skin care |
CN103432043B (en) * | 2013-08-30 | 2015-04-22 | 广州丹奇日用化工厂有限公司 | Face mask containing plant material residues |
US10307366B2 (en) * | 2016-03-03 | 2019-06-04 | Access Business Group International Llc | Composition and related method for inhibiting moisture loss from skin |
FR3061416B1 (en) * | 2016-12-29 | 2021-06-18 | Basf Beauty Care Solutions France Sas | USE OF COCONUT WATER AS AN EXTRACTION SOLVENT |
FR3068251B1 (en) | 2017-06-29 | 2019-08-23 | Laboratoires M&L | COSMETIC COMPOSITION COMPRISING ESSENTIAL IMMORTELLE OIL AND EXTRACT OF ORIGANUM |
CN108904334A (en) * | 2018-09-03 | 2018-11-30 | 芜湖凌梦电子商务有限公司 | Scar of dispelling repairs face cream and preparation method thereof |
-
2019
- 2019-10-30 WO PCT/US2019/058822 patent/WO2020242516A1/en unknown
- 2019-10-30 CN CN201980096575.9A patent/CN113853195B/en active Active
- 2019-10-30 JP JP2021570139A patent/JP2022534485A/en not_active Withdrawn
- 2019-10-30 US US16/669,098 patent/US10682306B1/en active Active
- 2019-10-30 EP EP19813984.2A patent/EP3976205A1/en active Pending
-
2020
- 2020-06-15 US US16/901,795 patent/US20200375887A1/en not_active Abandoned
-
2022
- 2022-08-10 US US17/818,749 patent/US20220378690A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150328087A1 (en) * | 2014-05-16 | 2015-11-19 | Restorsea, Llc | Biphasic cosmetic |
Also Published As
Publication number | Publication date |
---|---|
US20200375887A1 (en) | 2020-12-03 |
WO2020242516A1 (en) | 2020-12-03 |
JP2022534485A (en) | 2022-08-01 |
CN113853195A (en) | 2021-12-28 |
CN113853195B (en) | 2024-07-26 |
US10682306B1 (en) | 2020-06-16 |
EP3976205A1 (en) | 2022-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6968534B2 (en) | Topical composition containing Pichia anomala and chicory root extract | |
US8101214B2 (en) | Composition for skin external application containing complex of herbal extracts | |
EP2370052B1 (en) | Novel sebum secretion inhibitory agent | |
US20220378690A1 (en) | Compositions and methods for treating skin | |
CN106333898A (en) | Multi-moisturizing double-layer makeup remover and preparation method thereof | |
CN111166683A (en) | Fullerene anti-aging antioxidant beauty and skin care cosmetic and preparation method thereof | |
WO2008139182A2 (en) | Skin care composition | |
KR101909980B1 (en) | Cosmetic composition containing moisturizing complex | |
CN108969446A (en) | It is a kind of enhance skin barrier function infant prevent chapped skin care compositions and preparation method thereof | |
KR20070081192A (en) | Cosmetic composition containing liposome containing oryzanol, rice bran oil and phospholipid as active ingredient | |
KR20090041886A (en) | Vegetable triple moisturizing component and skin care composition comprising the same | |
CN113425661A (en) | Plant composition with cleaning and repairing effects and application thereof | |
CN106333886B (en) | Composition with moisturizing, whitening and skin-brightening effects and application thereof | |
CN111544348A (en) | Wrinkle-removing cream and preparation method thereof | |
CN112891292B (en) | A moisturizing facial cleanser containing natural plant effective components for removing speckle, caring skin, and nourishing skin, and its preparation method | |
KR20110052095A (en) | Cosmetic composition for moisturizing skin containing mushroom extract | |
CN113679640A (en) | Natural nourishing skin-cleaning skin-care acne-removing facial cleansing gel and preparation method thereof | |
CN112754963A (en) | Application method of firming anti-wrinkle skin care product | |
KR100574233B1 (en) | Cosmetic composition containing plant extracts having skin moisturizing and anti-irritant effects | |
KR102162377B1 (en) | Extracts derived from natural products and cosmetic composition containing the same, and process for producing the same | |
CN113476385A (en) | A bath gel containing multiple natural plant effective components for whitening skin, benefiting skin and repairing skin, and its preparation method | |
CN111388360A (en) | Bathing essential oil and preparation method thereof | |
RU2831654C1 (en) | Skin washing composition | |
KR102281403B1 (en) | Cosmetic composition for improving skin wrinkles containing Torreya nucifera ceramide and extracts of Curcuma and defatted camellia seeds | |
WO2024052756A1 (en) | Use of an extract of sichuan pepper for a skin treatment and a composition suitable for this use. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: CODEX BEAUTY CORPORATION, CALIFORNIA Free format text: CHANGE OF NAME;ASSIGNOR:CODEX BEAUTY LLC;REEL/FRAME:061129/0937 Effective date: 20190627 Owner name: CODEX BEAUTY LLC, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:RYAN, TRACEY;CORNELL, MARC;PALDUS, BARBARA A.;SIGNING DATES FROM 20191026 TO 20191030;REEL/FRAME:061132/0463 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: CODEX LABS CORPORATION, CALIFORNIA Free format text: CHANGE OF NAME;ASSIGNOR:CODEX BEAUTY CORPORATION;REEL/FRAME:061535/0419 Effective date: 20211209 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE |